| RF_ID |
Disease Name |
Species |
RF_Name |
Association |
Phase |
Condition |
Year |
PMID |
| 3372 |
Amyotrophic Lateral Sclerosis |
Human |
Rare CNVs |
RF |
|
|
2008 |
18313986 |
| 3825 |
Parkinson disease |
Human |
TMEM |
RF |
Diagnosis |
|
2021 |
33279243 |
| 3826 |
Parkinson disease |
Human |
TMEM |
RF |
Diagnosis |
|
2021 |
33279243 |
| 2204 |
Alzheimer's Disease |
Human |
TMEM |
RF |
|
APOE-?2 |
2021 |
33576571 |
| 4007 |
Fatal familial insomnia (FFI) |
Human |
SRSF11 |
RF |
Diagnosis |
These genetic variants are absent in FFI patients with early disease onset (19-40 years) |
2023 |
37626863 |
| 4009 |
Fatal familial insomnia (FFI) |
Human |
SRSF11 |
RF |
Diagnosis |
These genetic variants are absent in FFI patients with early disease onset (19-40 years) |
2023 |
37626863 |
| 4008 |
Fatal familial insomnia (FFI) |
Human |
SRSF11 |
RF |
Diagnosis |
These genetic variants are absent in FFI patients with early disease onset (19-40 years) |
2023 |
37626863 |
| 4000 |
Fatal familial insomnia (FFI) |
Human |
NR1H9P |
RF |
Diagnosis |
These genetic variants are absent in FFI patients with early disease onset (19-40 years) |
2023 |
37626863 |
| 3999 |
Fatal familial insomnia (FFI) |
Human |
NR1H8P |
RF |
Diagnosis |
These genetic variants are absent in FFI patients with early disease onset (19-40 years) |
2023 |
37626863 |
| 3998 |
Fatal familial insomnia (FFI) |
Human |
NR1H7P |
RF |
Diagnosis |
These genetic variants are absent in FFI patients with early disease onset (19-40 years) |
2023 |
37626863 |
| 3997 |
Fatal familial insomnia (FFI) |
Human |
NR1H6P |
RF |
Diagnosis |
These genetic variants are absent in FFI patients with early disease onset (19-40 years) |
2023 |
37626863 |
| 3996 |
Fatal familial insomnia (FFI) |
Human |
NR1H5P |
RF |
Diagnosis |
These genetic variants are absent in FFI patients with early disease onset (19-40 years) |
2023 |
37626863 |
| 4001 |
Fatal familial insomnia (FFI) |
Human |
NR1H10P |
RF |
Diagnosis |
These genetic variants are absent in FFI patients with early disease onset (19-40 years) |
2023 |
37626863 |
| 4010 |
Fatal familial insomnia (FFI) |
Human |
MSANTD3 |
RF |
Diagnosis |
These genetic variants are absent in FFI patients with early disease onset (19-40 years) |
2023 |
37626863 |
| 4012 |
Fatal familial insomnia (FFI) |
Human |
MSANTD3 |
RF |
Diagnosis |
These genetic variants are absent in FFI patients with early disease onset (19-40 years) |
2023 |
37626863 |
| 4014 |
Fatal familial insomnia (FFI) |
Human |
MSANTD3 |
RF |
Diagnosis |
These genetic variants are absent in FFI patients with early disease onset (19-40 years) |
2023 |
37626863 |
| 4011 |
Fatal familial insomnia (FFI) |
Human |
MSANTD3 |
RF |
Diagnosis |
These genetic variants are absent in FFI patients with early disease onset (19-40 years) |
2023 |
37626863 |
| 4013 |
Fatal familial insomnia (FFI) |
Human |
MSANTD3 |
RF |
Diagnosis |
These genetic variants are absent in FFI patients with early disease onset (19-40 years) |
2023 |
37626863 |
| 4016 |
Amyotrophic Lateral Sclerosis |
Human |
HTT |
RF |
Diagnosis |
|
2023 |
36599142 |
| 4002 |
Fatal familial insomnia (FFI) |
Human |
GNA13P1 |
RF |
Diagnosis |
These genetic variants are absent in FFI patients with early disease onset (19-40 years) |
2023 |
37626863 |
| 4003 |
Fatal familial insomnia (FFI) |
Human |
GNA13P1 |
RF |
Diagnosis |
These genetic variants are absent in FFI patients with early disease onset (19-40 years) |
2023 |
37626863 |
| 4005 |
Fatal familial insomnia (FFI) |
Human |
EXOC1L |
RF |
Diagnosis |
These genetic variants are absent in FFI patients with early disease onset (19-40 years) |
2023 |
37626863 |
| 4004 |
Fatal familial insomnia (FFI) |
Human |
EXOC1L |
RF |
Diagnosis |
These genetic variants are absent in FFI patients with early disease onset (19-40 years) |
2023 |
37626863 |
| 4006 |
Fatal familial insomnia (FFI) |
Human |
EXOC1L |
RF |
Diagnosis |
These genetic variants are absent in FFI patients with early disease onset (19-40 years) |
2023 |
37626863 |
| 1839 |
Alzheimer's Disease |
Human |
MT-ND2 |
RF |
Diagnosis |
|
2023 |
34854014 |
| 1840 |
Alzheimer's Disease |
Human |
MT-ND5 |
RF |
Diagnosis |
|
2023 |
34854014 |
| 3991 |
Amyotrophic Lateral Sclerosis |
Human |
hsa-miR-152-3p |
RF |
Diagnosis |
|
2023 |
37261630 |
| 929 |
Amyotrophic Lateral Sclerosis |
Human |
hsa-miR-139-5p |
PF |
Diagnosis |
|
2023 |
37261630 |
| 928 |
Amyotrophic Lateral Sclerosis |
Human |
hsa-miR-27b-3p |
PF |
Diagnosis |
|
2023 |
37261630 |
| 3990 |
Tourette Syndrome |
Human |
ASH1L |
RF |
Diagnosis |
|
2022 |
35307981 |
| 3989 |
Tourette Syndrome |
Human |
ASH1L |
RF |
Diagnosis |
|
2022 |
35307981 |
| 685 |
Lewy Body Disease |
Human |
Mitochondrial genomic variation |
PF |
Diagnosis |
|
2022 |
35836284 |
| 3986 |
Amyotrophic Lateral Sclerosis |
human and mice |
SARM1 |
RF |
Diagnosis |
|
2022 |
34991663 |
| 1912 |
Amyotrophic Lateral Sclerosis |
Human |
APOB |
RF |
Diagnosis |
|
2023 |
37688479 |
| 1947 |
Amyotrophic Lateral Sclerosis |
Human |
HMGCR |
RF |
Diagnosis |
|
2023 |
37688479 |
| 1666 |
Amyotrophic Lateral Sclerosis |
Human |
LRP1 |
RF |
Diagnosis |
|
2023 |
37142397 |
| 1571 |
Amyotrophic Lateral Sclerosis |
Human |
THSD7A |
RF |
Diagnosis |
|
2023 |
37142397 |
| 1677 |
Amyotrophic Lateral Sclerosis |
Human |
FGF1 |
RF |
Diagnosis |
|
2023 |
37142397 |
| 1829 |
Parkinson disease |
Human |
MIDN |
RF |
Diagnosis |
|
2023 |
36858566 |
| 3953 |
Parkinson disease |
Human |
CD4 |
RF |
Diagnosis |
|
2022 |
36224715 |
| 3952 |
Parkinson disease |
Human |
CD4 |
RF |
Diagnosis |
|
2022 |
36224715 |
| 1710 |
Parkinson disease |
Human |
LRP1B |
RF |
Prognosis |
|
2023 |
36348503 |
| 2021 |
Parkinson disease |
Human |
DRD4 |
RF |
Diagnosis |
|
2022 |
35532648 |
| 2090 |
Parkinson disease |
Human |
DRD4 |
RF |
Diagnosis |
|
2022 |
35532648 |
| 3938 |
Alzheimer's Disease |
Human |
MYO15A |
RF |
Diagnosis |
|
2023 |
36788216 |
| 3937 |
Alzheimer's Disease |
Human |
COX7C |
RF |
Diagnosis |
|
2023 |
36788216 |
| 2264 |
Alzheimer's Disease |
Human |
ABCA1 |
RF |
Diagnosis |
|
2022 |
36411364 |
| 3936 |
Alzheimer's Disease |
Human |
ABCA1 |
RF |
Diagnosis |
|
2023 |
36788216 |
| 2118 |
Alzheimer's Disease |
Human |
ATP8B4 |
RF |
Diagnosis |
|
2022 |
36411364 |
| 3930 |
Alzheimer's Disease |
Human |
IDE |
RF |
Diagnosis |
|
2022 |
35236268 |
| 3926 |
Alzheimer's Disease |
Human |
Hsa-miR-320a |
RF |
Diagnosis |
related to AD and depression |
2022 |
36040555 |
| 3925 |
Alzheimer's Disease |
Human |
Hsa-miR-451a |
RF |
Diagnosis |
related to AD and depression |
2022 |
36040555 |
| 3924 |
Alzheimer's Disease |
Human |
Hsa-miR-27a-3p |
RF |
Diagnosis |
related to AD and depression |
2022 |
36040555 |
| 3923 |
Alzheimer's Disease |
Human |
Hsa-miR-664a-3p |
RF |
Diagnosis |
related to AD and depression |
2022 |
36040555 |
| 3922 |
Alzheimer's Disease |
Human |
Hsa-miR-181c-5p |
RF |
Diagnosis |
related to AD and depression |
2022 |
36040555 |
| 3920 |
Alzheimer's Disease |
Human |
Hsa-miR-497-5p |
RF |
Diagnosis |
related to AD and education |
2022 |
36040555 |
| 3919 |
Alzheimer's Disease |
Human |
Hsa-miR-20a-5p |
RF |
Diagnosis |
related to AD and education |
2022 |
36040555 |
| 3921 |
Alzheimer's Disease |
Human |
Hsa-miR-185-5p |
RF |
Diagnosis |
related to AD and depression |
2022 |
36040555 |
| 3918 |
Alzheimer's Disease |
Human |
Hsa-miR-185-5p |
RF |
Diagnosis |
related to AD and education |
2022 |
36040555 |
| 3904 |
Alzheimer's Disease |
Human |
NOTCH2 |
RF |
Diagnosis |
|
2023 |
37355909 |
| 2220 |
Alzheimer's Disease |
Human |
5, 10-methylenetetrahydrofolate dehydrogenase gene (MTHFD1) |
RF |
|
|
2010 |
20217437 |
| 2267 |
Alzheimer's Disease |
Human |
5-HTT |
RF |
|
homozygous low activity genotype: ε4 alleles of the ApoE gene |
1997 |
9106747 |
| 2305 |
Alzheimer's Disease |
Human |
5-LO |
RF |
|
A allele |
2010 |
20110601 |
| 3147 |
Amyotrophic Lateral Sclerosis |
Human |
A90V TDP-43 variant |
RF |
|
|
2008 |
18505686 |
| 767 |
Parkinson disease |
Human |
ABCA7 |
PF |
Diagnosis |
|
2022 |
35709878 |
| 721 |
Alzheimer's Disease |
Human |
ABCA7 |
PF |
|
National Alzheimer’s Coordinating Center (NACC) cohort |
2018 |
30128317 |
| 3955 |
Parkinson disease |
Human |
ABCA7 |
RF |
Diagnosis |
|
2022 |
35709878 |
| 2972 |
Alzheimer's Disease |
Human |
ABCA7 |
RF |
|
|
2018 |
29589097 |
| 3149 |
Alzheimer's Disease |
Human |
ABCA7 |
RF |
|
|
2018 |
29589097 |
| 3148 |
Alzheimer's Disease |
Human |
ABCA7 |
RF |
|
|
2018 |
29589097 |
| 1974 |
Alzheimer's Disease |
Human |
ABCA7 |
RF |
|
Calculated by fixed effect model |
2018 |
29504051 |
| 1942 |
Alzheimer's Disease |
Human |
ABCA7 |
RF |
|
|
2016 |
26795201 |
| 3150 |
Alzheimer's Disease |
Human |
ABCA7 |
RF |
|
with both ApoEε4-carrier and aging being factors enhancing its risk |
2014 |
24113560 |
| 2986 |
Alzheimer's Disease |
Human |
ABCA8 |
RF |
|
APOE-?2 |
2021 |
33576571 |
| 2900 |
Alzheimer's Disease |
Human |
ABCA8 |
RF |
|
APOE-?2 |
2021 |
33576571 |
| 3110 |
Parkinson disease |
Human |
ABCB1 |
RF |
|
|
2014 |
24572589 |
| 546 |
Alzheimer's Disease |
Human |
ACAT1 |
PF |
|
|
2021 |
33057949 |
| 2349 |
Alzheimer's Disease |
Human |
ACAT1 |
RF |
|
|
2021 |
33057949 |
| 3152 |
Alzheimer's Disease |
Human |
ACE |
RF |
|
in subjects aged 73 years and above. |
2009 |
19539712 |
| 2495 |
Alzheimer's Disease |
Human |
ACE |
RF |
|
|
2000 |
11078932 |
| 2023 |
Parkinson disease |
Human |
ACE |
RF |
|
|
2002 |
12084438 |
| 3151 |
Alzheimer's Disease |
Human |
ACE |
RF |
|
|
2010 |
21537449 |
| 3153 |
Alzheimer's Disease |
Human |
ACE |
RF |
|
in subjects aged 73 years and above. |
2009 |
19539712 |
| 3835 |
Parkinson disease |
Human |
ACE |
RF |
Prognosis |
|
2021 |
34945793 |
| 2022 |
Parkinson disease |
Human |
ACE |
RF |
|
|
2002 |
12084438 |
| 1896 |
Alzheimer's Disease |
Human |
ACT |
RF |
|
especially in Caucasians |
2012 |
22294107 |
| 1976 |
Alzheimer's Disease |
Human |
ACT |
RF |
|
especially in Caucasians |
2012 |
22294107 |
| 3154 |
Multiple System Atrophy |
Human |
ACT |
RF |
|
|
2005 |
15907346 |
| 1894 |
Alzheimer's Disease |
Human |
ACT |
RF |
|
A allele carriers are associated with increased susceptibility to AD in variant populations |
2013 |
22272609 |
| 1897 |
Alzheimer's Disease |
Human |
ACT |
RF |
|
A allele carriers are associated with increased susceptibility to AD in variant populations |
2013 |
22272609 |
| 2889 |
Parkinson disease |
Human |
ADAM10 |
RF |
|
|
2021 |
33527480 |
| 2513 |
Parkinson disease |
Human |
ADH1B |
RF |
|
|
2019 |
30483881 |
| 512 |
Alzheimer's Disease |
Human |
ADH1C |
PF |
|
|
2021 |
33551739 |
| 3811 |
Lewy Body Disease |
Human |
AD-PRS |
RF |
Diagnosis |
|
2021 |
34308904 |
| 1951 |
Alzheimer's Disease |
Human |
AKNAD1 |
RF |
|
APOE-?3 |
2021 |
33576571 |
| 756 |
Alzheimer's Disease |
Human |
AKNAD1 |
PF |
|
APOE-?3 |
2021 |
33576571 |
| 2337 |
Alzheimer's Disease |
Human |
AKNAD1 |
RF |
|
APOE-?2 |
2021 |
33576571 |
| 2803 |
Alzheimer's Disease |
Human |
ALDH2 |
RF |
|
dependent on APOE epsilon4 status in Chinese |
2008 |
18201725 |
| 691 |
Alzheimer's Disease |
Human |
ALDH5A1 |
PF |
|
APOE-?3 |
2021 |
33576571 |
| 3155 |
Alzheimer's Disease |
Human |
ALOX5 |
RF |
|
|
2016 |
26944113 |
| 2325 |
Alzheimer's Disease |
Human |
ANK1 |
RF |
|
|
2016 |
26611832 |
| 3856 |
Parkinson disease |
Human |
ANKK1 |
RF |
|
|
2021 |
34151861 |
| 1656 |
Alzheimer's Disease |
Human |
APOC1 |
RF |
|
using Cox regression、Dataset:FHS(Framingham Heart Study) |
2018 |
29107063 |
| 3157 |
Alzheimer's Disease |
Human |
APOC1 |
RF |
|
not in African Americans |
2014 |
24498013 |
| 3156 |
Alzheimer's Disease |
Human |
APOC1 |
RF |
|
|
2018 |
30443289 |
| 1670 |
Alzheimer's Disease |
Human |
APOC1 |
RF |
|
using Cox regression、Dataset:CHS(Cardiovascular Health Study) |
2018 |
29107063 |
| 2536 |
Alzheimer's Disease |
Human |
APOC1 |
RF |
|
using logistic regression、Dataset:FHS(Framingham Heart Study) |
2018 |
29107063 |
| 3158 |
Alzheimer's Disease |
Human |
APOD |
RF |
|
in APOEε4 (-) subgroup |
2013 |
23690001 |
| 2260 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
using logistic regression、Dataset:LOADFS(Late Onset Alzheimer's Disease Family Study ) |
2018 |
29107063 |
| 826 |
Frontotemporal Dementia |
Human |
APOE |
PF |
|
|
2017 |
28888721 |
| 3160 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
ε4 allele |
2018 |
29592889 |
| 2829 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
|
2019 |
30894904 |
| 2339 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
|
2010 |
19819468 |
| 3185 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
|
2008 |
18560129 |
| 2463 |
Alzheimer's Disease |
Human |
APOE |
RF |
Diagnosis |
|
2022 |
35135450 |
| 2601 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
A/A genotype |
2009 |
19172988 |
| 1848 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
|
2012 |
22068907 |
| 2272 |
Frontotemporal Lobar Degeneration |
Human |
APOE |
RF |
|
ε3ε4+ε4ε4 vs. ε3ε3 |
2017 |
28487499 |
| 3139 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
lowers age at onset of LOAD significantly |
2008 |
18416843 |
| 602 |
Alzheimer's Disease |
Human |
APOE |
PF |
|
ε2 allele |
2018 |
29990559 |
| 3166 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
ε4 allele |
1994 |
7977635 |
| 2610 |
Dementia with Lewy bodies |
Human |
APOE |
RF |
|
|
2018 |
29263008 |
| 3190 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
APOE haplotypes |
2014 |
24596166 |
| 2754 |
Frontotemporal Dementia |
Human |
APOE |
RF |
|
|
2013 |
23887281 |
| 1761 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
|
2021 |
33397450 |
| 3171 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
|
2019 |
30890475 |
| 2929 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
|
2014 |
23871727 |
| 527 |
Alzheimer's Disease |
Human |
APOE |
PF |
|
National Alzheimer’s Coordinating Center (NACC) cohort; ε4 |
2018 |
30128317 |
| 2113 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
using logistic regression、Dataset:CHS( Cardiovascular Health Study) |
2018 |
29107063 |
| 697 |
Alzheimer's Disease |
Human |
APOE |
PF |
|
APOEε2ε3 |
2015 |
25673977 |
| 2289 |
Frontotemporal Lobar Degeneration |
Human |
APOE |
RF |
|
ε2ε2 vs. ε3ε3 |
2017 |
28487499 |
| 2807 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
Genotype: ε4/-; adjusted for age and education, and stratified by gender |
2018 |
30205398 |
| 3023 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
Genotype: ε4/4; adjusted for age and education, and stratified by gender |
2018 |
30205398 |
| 2936 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
|
2010 |
20217437 |
| 3082 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
|
2002 |
12095653 |
| 3177 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
|
2015 |
26738348 |
| 822 |
Alzheimer's Disease |
Human |
APOE |
PF |
|
|
2012 |
22068907 |
| 3182 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
The rate of APOE4 carrier status and the frequency of the ε4 allele were 47% and 27% for LOAD, 50% and 31% for EOAD, |
2011 |
21552550 |
| 2505 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
ε4 allele |
2002 |
12160362 |
| 3162 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
ε4 allele |
1994 |
7841371 |
| 2348 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
|
2008 |
18446027 |
| 3187 |
Dementia with Lewy bodies |
Human |
APOE |
RF |
|
|
2014 |
24973356 |
| 2750 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
|
2014 |
24281128 |
| 3666 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
|
2020 |
32043803 |
| 1717 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
|
2014 |
24045327 |
| 562 |
Dementia with Lewy bodies |
Human |
APOE |
PF |
|
|
2019 |
30798004 |
| 3014 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
Genotype: ?3/?4; AD without depression |
2018 |
29703883 |
| 3168 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
|
1996 |
8993485 |
| 2697 |
Frontotemporal Dementia |
Human |
APOE |
RF |
|
|
2006 |
15904995 |
| 1572 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
using Cox regression、Dataset:CHS(Cardiovascular Health Study) |
2018 |
29107063 |
| 2356 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
Gender: female; Calculated by Forced entry model |
1999 |
10213175 |
| 3192 |
Progressive Supranuclear Palsy |
Human |
APOE |
RF |
|
|
2003 |
12552038 |
| 2759 |
Dementia with Lewy bodies |
Human |
APOE |
RF |
|
|
2019 |
30798004 |
| 1771 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
|
2018 |
30450407 |
| 2522 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
Genotype: ε3/4; adjusted for age and education, and stratified by gender |
2018 |
30205398 |
| 3174 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
|
2016 |
27033052 |
| 2855 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
Carrying at least one ε4 allele; Calculated by Step-wise model |
1999 |
10213175 |
| 2898 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
Individuals with 2 epsilon 4 alleles had a higher risk for AD than subjects with only 1 such allele |
2008 |
18317248 |
| 2734 |
Alzheimer's Disease |
Human |
APOE |
RF |
Diagnosis |
with APOE*4?allele |
2023 |
36528961 |
| 2939 |
Creutzfeldt-Jakob disease |
Human |
APOE |
RF |
|
ε4 allele |
1994 |
7968026 |
| 2449 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
APOE ε4ε4 |
2015 |
25673977 |
| 3086 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
ε4 allele |
2001 |
11376902 |
| 3179 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
|
2013 |
23887281 |
| 2864 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
ε4 allele; associated with heterozygosity |
1994 |
8128961 |
| 825 |
Frontotemporal Dementia |
Human |
APOE |
PF |
|
|
2002 |
12107813 |
| 3159 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
|
2012 |
22712640 |
| 2823 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
at least one epsilon 4 allele |
1995 |
8786847 |
| 3044 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
PENN cohort; ε2 |
2018 |
30128317 |
| 3184 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
|
2010 |
20385913 |
| 1679 |
Parkinson disease |
Human |
APOE |
RF |
Prognosis |
|
2023 |
36348503 |
| 2509 |
Dementia with Lewy bodies |
Human |
APOE |
RF |
|
4 allele |
2006 |
16956959 |
| 3164 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
ε2 allele |
2018 |
29562509 |
| 2350 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
Genotype: ε3/4; adjusted for age and education, and stratified by gender |
2018 |
30205398 |
| 3189 |
Dementia with Lewy bodies |
Human |
APOE |
RF |
|
The rate of APOE4 carrier status and the frequency of the ε4 allele were 42% and 31% for DLB |
2011 |
21552550 |
| 2753 |
Frontotemporal Lobar Degeneration |
Human |
APOE |
RF |
|
ε4 allele |
2013 |
23887281 |
| 1722 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
|
2011 |
21649613 |
| 2231 |
Frontotemporal Lobar Degeneration |
Human |
APOE |
RF |
|
ε4 vs. ε3 allele model |
2017 |
28487499 |
| 571 |
Alzheimer's Disease |
Human |
APOE |
PF |
|
ε3 allele |
2014 |
24632849 |
| 2146 |
Frontotemporal Lobar Degeneration |
Human |
APOE |
RF |
|
ε4 vs. ε2+ε3+ε4 allele model |
2017 |
28487499 |
| 3170 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
|
2019 |
30991302 |
| 2847 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
Th1/E47cs polymorphism allele |
2002 |
12095653 |
| 3194 |
Dementia with Lewy bodies |
Human |
APOE |
RF |
|
|
2016 |
27312774 |
| 521 |
Frontotemporal Dementia |
Human |
APOE |
PF |
|
|
2006 |
15904995 |
| 2976 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
ε4 allele; AD without depression |
2018 |
29703883 |
| 2675 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
Genotype: ε3/4; adjusted for age and education, and stratified by gender |
2018 |
30205398 |
| 2894 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
ε4 allele; AD all |
2018 |
29703883 |
| 2717 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
Genotype: AA |
1999 |
10213175 |
| 1643 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
|
2020 |
32767997 |
| 3176 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
The ε4 allele increases the risk of Alzheimer's disease by 5.114 times |
2016 |
26835020 |
| 2366 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
Gender: female; Calculated by Step-wise model |
1999 |
10213175 |
| 2298 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
Genotype/Allele: A/A |
2018 |
29990559 |
| 3181 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
|
2011 |
21556001 |
| 2774 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
Genotype: ?4/?4; AD without depression |
2018 |
29703883 |
| 2375 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
APOE ε3ε4 |
2015 |
25673977 |
| 719 |
Alzheimer's Disease |
Human |
APOE |
PF |
|
Genotype/Allele: T |
2018 |
29990559 |
| 3161 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
ε4 allele |
2018 |
30112972 |
| 2912 |
Alzheimer's Disease |
Human |
APOE |
RF |
Diagnosis |
|
2022 |
35135450 |
| 2606 |
Creutzfeldt-Jakob disease |
Human |
APOE |
RF |
|
ε4 allele |
1994 |
7968026 |
| 2340 |
Frontotemporal Lobar Degeneration |
Human |
APOE |
RF |
|
ε2ε2 vs. ε3ε3+ε3ε2 |
2017 |
28487499 |
| 3186 |
Frontotemporal Dementia |
Human |
APOE |
RF |
|
|
2013 |
23887281 |
| 2957 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
|
2018 |
29307083 |
| 2140 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
|
2008 |
18317248 |
| 3065 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
|
2011 |
22737475 |
| 3799 |
Lewy Body Disease |
Human |
APOE |
RF |
|
|
2021 |
34308904 |
| 2315 |
Creutzfeldt-Jakob disease |
Human |
APOE |
RF |
|
ε4 allele |
1994 |
7968026 |
| 3167 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
|
1997 |
9008509 |
| 2696 |
Frontotemporal Lobar Degeneration |
Human |
APOE |
RF |
|
ε4 allele |
2006 |
15904995 |
| 2433 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
|
2002 |
12095653 |
| 2844 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
Carrying at least one ε4 allele; Calculated by Forced entry model |
1999 |
10213175 |
| 3191 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
?4 allele |
2015 |
23038715 |
| 2755 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
National Alzheimer’s Coordinating Center (NACC) cohort; ε2 |
2018 |
30128317 |
| 1762 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
|
2020 |
32485802 |
| 2480 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
APOE ε4 |
2000 |
10912224 |
| 1620 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
using Cox regression、Dataset:HRS(Health and Retirement Study) |
2018 |
29107063 |
| 625 |
Alzheimer's Disease |
Human |
APOE |
PF |
|
Genotype/Allele: A/T |
2018 |
29990559 |
| 2208 |
Frontotemporal Lobar Degeneration |
Human |
APOE |
RF |
|
ε3ε4 vs. ε3ε3 |
2017 |
28487499 |
| 3172 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
|
2017 |
28461186 |
| 2851 |
Dementia with Lewy bodies |
Human |
APOE |
RF |
|
|
2002 |
12411758 |
| 532 |
Alzheimer's Disease |
Human |
APOE |
PF |
|
ε3 allele |
2018 |
29990559 |
| 2982 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
ε4 allele; associated with homozygosity |
1994 |
8128961 |
| 3695 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
|
2021 |
34336000 |
| 2897 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
Genotype: ?3/?4; AD all |
2018 |
29703883 |
| 2728 |
Frontotemporal Lobar Degeneration |
Human |
APOE |
RF |
|
ε4ε4 vs. ε3ε3+ε3ε4 |
2017 |
28487499 |
| 2938 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
|
2014 |
23871727 |
| 2592 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
Genotype: ε4/-; adjusted for age and education, and stratified by gender |
2018 |
30205398 |
| 3178 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
|
2014 |
24326531 |
| 2368 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
using logistic regression、Dataset:HRS(Health and Retirement Study) |
2018 |
29107063 |
| 542 |
Alzheimer's Disease |
Human |
APOE |
PF |
|
|
2008 |
18317248 |
| 2126 |
Frontotemporal Lobar Degeneration |
Human |
APOE |
RF |
|
ε4 vs. ε2+ε3+ε4 carrier model |
2017 |
28487499 |
| 2906 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
ε4 allele |
2014 |
24632849 |
| 1331 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
|
2010 |
20376800 |
| 2818 |
Frontotemporal Lobar Degeneration |
Human |
APOE |
RF |
|
ε4ε4 vs. ε3ε3 |
2017 |
28487499 |
| 3042 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
Genotype: ε4/4; adjusted for age and education, and stratified by gender |
2018 |
30205398 |
| 3183 |
Alzheimer's Disease |
human and mice |
APOE |
RF |
|
nutritional imbalance |
2010 |
20413864 |
| 2646 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
|
2011 |
22311091 |
| 3163 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
ε2 allele |
1994 |
7824157 |
| 3188 |
Dementia with Lewy bodies |
Human |
APOE |
RF |
|
epsilon 4 allele |
1994 |
7970234 |
| 500 |
Alzheimer's Disease |
Human |
APOE |
PF |
|
PENN cohort; ε4 |
2018 |
30128317 |
| 3667 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
|
2020 |
32116259 |
| 2143 |
Frontotemporal Lobar Degeneration |
Human |
APOE |
RF |
|
ε4 vs. ε2 allele model |
2017 |
28487499 |
| 3015 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
Carrying at least one ε4 allele |
1999 |
10213175 |
| 2654 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
Genotype: ε4/-; adjusted for age and education, and stratified by gender |
2018 |
30205398 |
| 3169 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
|
1998 |
9811931 |
| 3193 |
Frontotemporal Dementia |
Human |
APOE |
RF |
|
|
2017 |
28888721 |
| 520 |
Frontotemporal Lobar Degeneration |
Human |
APOE |
PF |
|
ε2 allele |
2006 |
15904995 |
| 3080 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
|
2017 |
29348964 |
| 3175 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
|
2015 |
26885125 |
| 3115 |
Alzheimer's Disease |
Human |
APOE |
RF |
Diagnosis |
|
2022 |
35135450 |
| 2857 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
|
2011 |
20682755 |
| 705 |
Alzheimer's Disease |
Human |
APOE |
PF |
|
|
2008 |
18317248 |
| 3180 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
|
2011 |
21637534 |
| 2087 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
Genotype/Allele: A |
2018 |
29990559 |
| 1669 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
|
2021 |
33397450 |
| 3089 |
Alzheimer's Disease |
Human |
APOE |
RF |
|
ε4 allele |
2018 |
29990559 |
| 732 |
Alzheimer's Disease |
Human |
APOE ε2/ε3 |
PF |
|
|
2017 |
28846757 |
| 620 |
Alzheimer's Disease |
Human |
APOE ε2/ε3 |
PF |
|
|
2017 |
28846757 |
| 2828 |
Alzheimer's Disease |
Human |
APOE ε3/ε4 |
RF |
|
from ages 55 to 85 years |
2017 |
28846757 |
| 2794 |
Alzheimer's Disease |
Human |
APOE ε3/ε4 |
RF |
|
from ages 55 to 85 years |
2017 |
28846757 |
| 2793 |
Alzheimer's Disease |
Human |
ApoE ε4/ε3 |
RF |
|
ε4/ε3 genotype |
2014 |
24632849 |
| 2435 |
Alzheimer's Disease |
Human |
ApoE ε4/ε4 |
RF |
|
ε4/ε4 genotype |
2014 |
24632849 |
| 2946 |
Alzheimer's Disease |
Human |
APOE,ACT |
RF |
|
ACT Genotype: AA; One Copy of ε4 |
1996 |
8993481 |
| 3114 |
Alzheimer's Disease |
Human |
APOE,ACT |
RF |
|
ACT Genotype: AT; Two Copies of ε4 |
1996 |
8993481 |
| 2811 |
Alzheimer's Disease |
Human |
APOE,ACT |
RF |
|
ACT Genotype: TT; Two Copies of ε4 |
1996 |
8993481 |
| 2657 |
Alzheimer's Disease |
Human |
APOE,ACT |
RF |
|
ACT Genotype: TT; One Copy of ε4 |
1996 |
8993481 |
| 2915 |
Alzheimer's Disease |
Human |
APOE,ACT |
RF |
|
ACT Genotype: AA; Two Copies of ε4 |
1996 |
8993481 |
| 2813 |
Alzheimer's Disease |
Human |
APOE,ACT |
RF |
|
ACT Genotype: AT; One Copy of ε4 |
1996 |
8993481 |
| 2510 |
Frontotemporal Lobar Degeneration |
Human |
APOE,TOMM40 |
RF |
|
APOE-TOMM40 haplotype: ε4 GAC |
2013 |
23546992 |
| 869 |
Alzheimer's Disease |
Human |
APOE?2 |
PF |
|
substantially attenuated among Black people |
2021 |
34334408 |
| 2956 |
Alzheimer's Disease |
Human |
APOE?4 |
RF |
|
|
2021 |
33732104 |
| 2439 |
Parkinson disease |
Human |
APOE?4 |
RF |
|
|
2021 |
33057949 |
| 3805 |
Lewy Body Disease |
Human |
APOE?4 |
RF |
Diagnosis |
|
2021 |
33646158 |
| 3694 |
Alzheimer's Disease |
Human |
APOE?4 |
RF |
|
substantially attenuated among Black people |
2021 |
34334408 |
| 2591 |
Chronic Traumatic Encephalopathy |
Human |
APOE?4 |
RF |
Diagnosis |
|
2022 |
35759276 |
| 2642 |
Lewy Body Disease |
Human |
APOE?4 |
RF |
Diagnosis |
|
2021 |
34308904 |
| 3749 |
Alzheimer's Disease |
Human |
APOE?4 |
RF |
|
|
2021 |
33009037 |
| 2666 |
Alzheimer's Disease |
Human |
APOE?4 |
RF |
Diagnosis |
|
2023 |
37182880 |
| 3797 |
Frontotemporal Dementia |
Human |
APOE?4 |
RF |
Diagnosis |
in the C9orf72 noncarriers |
2021 |
32972771 |
| 3705 |
Alzheimer's Disease |
Human |
APOE?4 |
RF |
|
|
2021 |
34214049 |
| 3917 |
Alzheimer's Disease |
Human |
APOE?4 |
RF |
Diagnosis |
|
2022 |
36226340 |
| 3009 |
Alzheimer's Disease |
Human |
APOE?4 |
RF |
|
|
2021 |
33541779 |
| 3731 |
Alzheimer's Disease |
Human |
APOE?4 |
RF |
|
|
2021 |
33686543 |
| 3756 |
Alzheimer's Disease |
Human |
APOE?4 |
RF |
|
|
2021 |
33196771 |
| 3697 |
Alzheimer's Disease |
Human |
APOE?4 |
RF |
|
|
2021 |
34266503 |
| 1952 |
Parkinson disease |
Human |
apolipoprotein E ( APOE) ε3 allele |
RF |
|
|
2019 |
30526202 |
| 809 |
Parkinson disease |
Human |
apolipoprotein E ( APOE) ε3 allele |
PF |
|
|
2019 |
30526202 |
| 3555 |
Alzheimer's Disease |
Human |
Apolipoprotein E (APOE)-epsilon4 |
RF |
|
|
2018 |
29605385 |
| 871 |
Alzheimer's Disease |
Human |
apolipoprotein E ?3 |
PF |
|
|
2021 |
34258926 |
| 3556 |
Parkinson disease |
Human |
Apolipoprotein E4 |
RF |
|
|
2005 |
15924299 |
| 3195 |
Dementia with Lewy bodies |
Human |
APP |
RF |
|
|
2016 |
27312774 |
| 3914 |
Alzheimer's Disease |
Human |
APP |
RF |
Diagnosis |
|
2023 |
37145212 |
| 1800 |
Alzheimer's Disease |
Human |
Arg972 IRS1 |
RF |
|
A Allele |
2014 |
24589556 |
| 1819 |
Alzheimer's Disease |
Human |
Arg972 IRS1 |
RF |
|
AA genotype |
2014 |
24589556 |
| 1808 |
Alzheimer's Disease |
Human |
Arg972 IRS1 |
RF |
|
GA genotype |
2014 |
24589556 |
| 513 |
Alzheimer's Disease |
Human |
ARHGAP33 |
PF |
|
APOE-?3 |
2021 |
33576571 |
| 3196 |
Alzheimer's Disease |
Human |
ASTN2 |
RF |
|
|
2015 |
25410587 |
| 3197 |
Amyotrophic Lateral Sclerosis |
Human |
ATAXIN2 |
RF |
|
≥ 31 CAG-repeat length |
2012 |
22425256 |
| 2580 |
Alzheimer's Disease |
Human |
ATP10B |
RF |
|
|
2013 |
22950421 |
| 3668 |
Parkinson disease |
Human |
ATP10B |
RF |
|
recessive loss of function mutations |
2020 |
32172343 |
| 2640 |
Alzheimer's Disease |
Human |
ATP6V0E2 |
RF |
|
APOE-?2 |
2021 |
33576571 |
| 2142 |
Alzheimer's Disease |
Human |
ATP7B |
RF |
|
|
2013 |
22950421 |
| 2177 |
Alzheimer's Disease |
Human |
ATP8B |
RF |
|
|
2013 |
22950421 |
| 2284 |
Alzheimer's Disease |
Human |
ATP9B |
RF |
|
|
2013 |
22950421 |
| 2417 |
Amyotrophic Lateral Sclerosis |
Human |
ATRN |
RF |
|
|
2013 |
27455347 |
| 3980 |
Amyotrophic Lateral Sclerosis |
Human |
ATXN1 |
RF |
Diagnosis |
|
2022 |
35525134 |
| 3198 |
Amyotrophic Lateral Sclerosis |
Human |
ATXN1 |
RF |
|
|
2014 |
25023141 |
| 3203 |
Frontotemporal Lobar Degeneration |
Human |
ATXN2 |
RF |
|
ATXN2 intermediary repeat length>=29 |
2014 |
25098532 |
| 2841 |
Amyotrophic Lateral Sclerosis |
Human |
ATXN2 |
RF |
|
|
2019 |
30847648 |
| 3200 |
Amyotrophic Lateral Sclerosis |
Human |
ATXN2 |
RF |
|
|
2012 |
23197749 |
| 2991 |
Amyotrophic Lateral Sclerosis |
Human |
ATXN2 |
RF |
|
ATXN2 high-length alleles (≥29 CAG repeats) |
2011 |
21670397 |
| 3038 |
Amyotrophic Lateral Sclerosis |
Human |
ATXN2 |
RF |
|
CAG repeat length >30 |
2011 |
21610160 |
| 3202 |
Frontotemporal Dementia |
Human |
ATXN2 |
RF |
|
ATXN2 intermediary polyQ expansions |
2014 |
25098532 |
| 3073 |
Amyotrophic Lateral Sclerosis |
Human |
ATXN2 |
RF |
Diagnosis |
|
2022 |
35521889 |
| 3199 |
Amyotrophic Lateral Sclerosis |
Human |
ATXN2 |
RF |
|
|
2015 |
26208502 |
| 3981 |
Amyotrophic Lateral Sclerosis |
Human |
ATXN2 |
RF |
Diagnosis |
|
2022 |
35525134 |
| 3113 |
Amyotrophic Lateral Sclerosis |
Human |
ATXN2 |
RF |
|
ATXN2 high-length alleles (≥29 CAG repeats) |
2011 |
21670397 |
| 3201 |
Amyotrophic Lateral Sclerosis |
Human |
ATXN2 |
RF |
|
ATXN2 polyQ repeat expansions greater than 27 |
2011 |
21741123 |
| 2778 |
Amyotrophic lateral sclerosis with frontotemporal dementia |
Human |
ATXN2 |
RF |
Diagnosis |
|
2022 |
35521889 |
| 2700 |
Frontotemporal Dementia |
Human |
ATXN2 |
RF |
Diagnosis |
|
2022 |
35521889 |
| 2176 |
Amyotrophic Lateral Sclerosis |
Human |
ATXN2 |
RF |
|
CAG repeat length >26 |
2011 |
21610160 |
| 2323 |
Alzheimer's Disease |
Human |
AZU1 |
RF |
|
APOE-?2 |
2021 |
33576571 |
| 659 |
Alzheimer's Disease |
Human |
B3GAT2 |
PF |
|
APOE-?3 |
2021 |
33576571 |
| 2107 |
Alzheimer's Disease |
Human |
BACE1 |
RF |
|
with APOEε4 carrier status |
2015 |
26550136 |
| 2413 |
Alzheimer's Disease |
Human |
BACE1 |
RF |
|
in carrying the ApoE epsilon4 allele |
2008 |
18182766 |
| 1935 |
Alzheimer's Disease |
Human |
BACE2 |
RF |
|
Rheumatoid arthritis (RA) RA-SNPs Association with AD |
2011 |
21595938 |
| 592 |
Alzheimer's Disease |
Human |
BCL2L13 |
PF |
|
APOE-?2 |
2021 |
33576571 |
| 3833 |
Parkinson disease |
Human |
BDNF |
RF |
Prognosis |
|
2021 |
34945793 |
| 2353 |
Alzheimer's Disease |
Human |
BDNF C270T |
RF |
|
|
2015 |
26136901 |
| 1906 |
Alzheimer's Disease |
Human |
BIN1 |
RF |
|
Calculated by random effect model |
2018 |
29504051 |
| 3205 |
Alzheimer's Disease |
Human |
BIN1 |
RF |
|
|
2017 |
26768592 |
| 3067 |
Alzheimer's Disease |
Human |
BIN1 |
RF |
|
|
2021 |
33732104 |
| 1920 |
Alzheimer's Disease |
Human |
BIN1 |
RF |
|
Calculated by fixed effect model |
2018 |
29504051 |
| 714 |
Alzheimer's Disease |
Human |
BIN1 |
PF |
|
National Alzheimer’s Coordinating Center (NACC) cohort |
2018 |
30128317 |
| 682 |
Alzheimer's Disease |
Human |
BIN1 |
PF |
|
National Alzheimer’s Coordinating Center (NACC) cohort |
2018 |
30128317 |
| 1916 |
Alzheimer's Disease |
Human |
BIN1 |
RF |
|
Calculated by random effect model |
2018 |
29504051 |
| 3204 |
Alzheimer's Disease |
Human |
BIN1 |
RF |
|
|
2017 |
26768592 |
| 1910 |
Alzheimer's Disease |
Human |
BIN1 |
RF |
|
Calculated by fixed effect model |
2018 |
29504051 |
| 1891 |
Alzheimer's Disease |
Human |
BIN1 |
RF |
|
Calculated by fixed effect model |
2018 |
29504051 |
| 2948 |
Amyotrophic Lateral Sclerosis |
Human |
BIRC6 |
RF |
|
|
2013 |
27455347 |
| 744 |
Alzheimer's Disease |
Human |
BMS1 |
PF |
|
APOE-?3 |
2021 |
33576571 |
| 2441 |
Alzheimer's Disease |
Human |
C1orf185 |
RF |
|
APOE-?2 |
2021 |
33576571 |
| 2865 |
Amyotrophic Lateral Sclerosis |
Human |
C1QTNF7 |
RF |
|
|
2013 |
27455347 |
| 828 |
Alzheimer's Disease |
Human |
C282Y HFE |
PF |
|
|
2009 |
19429178 |
| 2860 |
Frontotemporal Lobar Degeneration |
Human |
C4orf27 |
RF |
|
Discovery stage |
2019 |
30739198 |
| 3206 |
Amyotrophic Lateral Sclerosis |
Human |
C7orf57 |
RF |
|
|
2014 |
25023141 |
| 3208 |
Amyotrophic Lateral Sclerosis |
Human |
C9orf72 |
RF |
|
|
2018 |
29528390 |
| 2875 |
Parkinson disease |
Human |
C9orf72 |
RF |
|
|
2021 |
34440384 |
| 2447 |
Amyotrophic Lateral Sclerosis |
Human |
C9orf72 |
RF |
|
|
2020 |
33168078 |
| 2274 |
Parkinson disease |
Human |
C9orf72 |
RF |
|
|
2021 |
34440384 |
| 3207 |
Amyotrophic Lateral Sclerosis |
Human |
C9orf72 |
RF |
|
|
2014 |
25023141 |
| 3979 |
Amyotrophic Lateral Sclerosis |
Human |
C9orf72 |
RF |
Diagnosis |
|
2022 |
35525134 |
| 2409 |
Amyotrophic Lateral Sclerosis |
Human |
C9orf72 |
RF |
|
|
2010 |
20801718 |
| 3209 |
Frontotemporal Lobar Degeneration |
Human |
C9orf72 |
RF |
|
C9orf72 repeat expansions; All FTD patients with mutations had a positive family history for dementia or ALS |
2014 |
25108559 |
| 3027 |
Amyotrophic Lateral Sclerosis |
Human |
C9orf72 |
RF |
|
|
2020 |
33168078 |
| 2869 |
Amyotrophic Lateral Sclerosis |
Human |
C9orf72 |
RF |
Diagnosis |
|
2021 |
33563800 |
| 3051 |
Parkinson disease |
Human |
C9orf72 |
RF |
|
|
2013 |
23845100 |
| 2751 |
Alzheimer's Disease |
Human |
C9orf72 |
RF |
|
|
2021 |
33935096 |
| 3978 |
Amyotrophic Lateral Sclerosis |
Human |
C9orf72 |
RF |
Diagnosis |
|
2022 |
36511680 |
| 3820 |
Multiple System Atrophy |
Human |
C9orf72 |
RF |
Diagnosis |
|
2021 |
35007998 |
| 3669 |
Amyotrophic Lateral Sclerosis |
Human |
CACNA1H |
RF |
|
|
2020 |
32143681 |
| 1954 |
Alzheimer's Disease |
Human |
CALHM1 |
RF |
|
|
2010 |
20061624 |
| 729 |
Creutzfeldt-Jakob disease |
Human |
CALHM1 |
PF |
|
|
2012 |
22874670 |
| 2544 |
Creutzfeldt-Jakob disease |
Human |
CALHM1 |
RF |
|
Genotype:GG |
2012 |
22874670 |
| 3100 |
Alzheimer's Disease |
Human |
CALHM2 |
RF |
|
APOE-?3 |
2021 |
33576571 |
| 2281 |
Parkinson disease |
Human |
CARD15 |
RF |
|
|
2007 |
17174426 |
| 2926 |
Alzheimer's Disease |
Human |
CCDC60 |
RF |
|
APOE-?2 |
2021 |
33576571 |
| 3210 |
Parkinson disease |
Human |
CCDC62/HIP1R |
RF |
|
|
2015 |
25818163 |
| 1854 |
Parkinson disease |
Human |
CCL2 |
RF |
|
|
2019 |
30761072 |
| 1863 |
Parkinson disease |
Human |
CCL2 |
RF |
|
|
2019 |
30761072 |
| 1985 |
Parkinson disease |
Human |
CD14 |
RF |
|
|
2006 |
16337421 |
| 3211 |
Parkinson disease |
rat |
CD157/BST1 |
RF |
|
|
2014 |
24795584 |
| 3212 |
Alzheimer's Disease |
Human |
CD163L1 |
RF |
|
|
2017 |
29177109 |
| 3664 |
Alzheimer's Disease |
Human |
CD33 |
RF |
|
|
2020 |
32647856 |
| 3213 |
Alzheimer's Disease |
Human |
CD33 |
RF |
|
|
2012 |
22382309 |
| 901 |
Parkinson disease |
Human |
CD33 |
PF |
Diagnosis |
|
2021 |
33582190 |
| 593 |
Alzheimer's Disease |
Human |
CD33 |
PF |
|
in APOE e4 carriers |
2012 |
22167654 |
| 2162 |
Alzheimer's Disease |
Human |
CD33 |
RF |
Diagnosis |
|
2022 |
35408990 |
| 815 |
Alzheimer's Disease |
Human |
CD33 |
PF |
|
this association was not significant in Asians |
2016 |
26795201 |
| 3954 |
Parkinson disease |
Human |
CD33 |
RF |
Diagnosis |
|
2023 |
37479176 |
| 926 |
Parkinson disease |
Human |
CD33 |
PF |
Diagnosis |
|
2023 |
37479176 |
| 563 |
Alzheimer's Disease |
Human |
CD33 |
PF |
|
in APOE e4 carriers |
2012 |
22167654 |
| 630 |
Alzheimer's Disease |
Human |
CD36 |
PF |
|
Genotype: GT; Adjusting the physiological and biochemical factors, including age, FBG, BMI, SBP, DBP, HDLC [According to univariate analysis, there was a significant deviation (P<0.05)]. |
2018 |
30235742 |
| 2221 |
Alzheimer's Disease |
Human |
CD36 |
RF |
|
Genotype: Recessive |
2018 |
30235742 |
| 2389 |
Alzheimer's Disease |
Human |
CD36 |
RF |
|
Genotype: Dominant |
2018 |
30235742 |
| 664 |
Alzheimer's Disease |
Human |
CD36 |
PF |
|
Genotype: Dominant; Adjusting the physiological and biochemical factors, including age, FBG, BMI, SBP, DBP, HDLC [According to univariate analysis, there was a significant deviation (P<0.05)]. |
2018 |
30235742 |
| 641 |
Alzheimer's Disease |
Human |
CD36 |
PF |
|
Genotype: GT |
2018 |
30235742 |
| 2477 |
Alzheimer's Disease |
Human |
CD36 |
RF |
|
Genotype: GG; Adjusting the physiological and biochemical factors, including age, FBG, BMI, SBP, DBP, HDLC [According to univariate analysis, there was a significant deviation (P<0.05)]. |
2018 |
30235742 |
| 2247 |
Alzheimer's Disease |
Human |
CD36 |
RF |
|
Genotype: Dominant; Adjusting the physiological and biochemical factors, including age, FBG, BMI, SBP, DBP, HDLC [According to univariate analysis, there was a significant deviation (P<0.05)]. |
2018 |
30235742 |
| 2598 |
Alzheimer's Disease |
Human |
CD36 |
RF |
|
Genotype: GG |
2018 |
30235742 |
| 681 |
Alzheimer's Disease |
Human |
CD36 |
PF |
|
Genotype: Dominant |
2018 |
30235742 |
| 3670 |
Creutzfeldt-Jakob disease |
Human |
Cerebroside sulfotransferase (GAL3ST1) |
RF |
|
|
2020 |
32565065 |
| 2203 |
Alzheimer's Disease |
Human |
CHAT |
RF |
|
|
2016 |
27272392 |
| 3214 |
Alzheimer's Disease |
Human |
CHAT |
RF |
|
|
2008 |
18562794 |
| 2236 |
Alzheimer's Disease |
Human |
CHAT |
RF |
|
|
2016 |
27272392 |
| 3215 |
Dementia with Lewy bodies |
Human |
CHCHD2 |
RF |
|
|
2015 |
26561290 |
| 3216 |
Parkinson disease |
Human |
CHCHD2 |
RF |
|
|
2016 |
27626775 |
| 2878 |
Amyotrophic Lateral Sclerosis |
Human |
CHGB |
RF |
|
|
2009 |
20007371 |
| 2608 |
Amyotrophic Lateral Sclerosis |
Human |
CHGB |
RF |
|
|
2009 |
20007371 |
| 2551 |
Alzheimer's Disease |
Human |
CHI3L1 |
RF |
|
TT |
2019 |
30223258 |
| 2200 |
Alzheimer's Disease |
Human |
CHI3L1 |
RF |
|
CT+TT |
2019 |
30223258 |
| 680 |
Alzheimer's Disease |
Human |
CHI3L1 |
PF |
|
CG+GG |
2019 |
30223258 |
| 2127 |
Alzheimer's Disease |
Human |
CHI3L1 |
RF |
|
T allele |
2019 |
30223258 |
| 687 |
Alzheimer's Disease |
Human |
CHI3L1 |
PF |
|
G allele |
2019 |
30223258 |
| 2595 |
Creutzfeldt-Jakob disease |
Human |
CHN2 |
RF |
|
|
2012 |
22210626 |
| 3217 |
Alzheimer's Disease |
Human |
chromosome 12q24.22 |
RF |
|
|
2014 |
24361131 |
| 3218 |
Multiple System Atrophy |
Human |
chromosome 22 |
RF |
|
|
2017 |
29187220 |
| 3219 |
Multiple System Atrophy |
Human |
chromosome 22 |
RF |
|
|
2017 |
29187220 |
| 3223 |
Multiple System Atrophy |
Human |
chromosome 4 |
RF |
|
|
2017 |
29187220 |
| 3220 |
Multiple System Atrophy |
Human |
chromosome 4 |
RF |
|
|
2017 |
29187220 |
| 3222 |
Multiple System Atrophy |
Human |
chromosome 4 |
RF |
|
|
2017 |
29187220 |
| 3224 |
Multiple System Atrophy |
Human |
chromosome 4 |
RF |
|
|
2017 |
29187220 |
| 3221 |
Multiple System Atrophy |
Human |
chromosome 4 |
RF |
|
|
2017 |
29187220 |
| 3226 |
Multiple System Atrophy |
Human |
chromosome 5 |
RF |
|
|
2017 |
29187220 |
| 3225 |
Multiple System Atrophy |
Human |
chromosome 5 |
RF |
|
|
2017 |
29187220 |
| 2336 |
Alzheimer's Disease |
Human |
chromosome 9p21.3 |
RF |
|
|
2010 |
20427016 |
| 1991 |
Alzheimer's Disease |
Human |
chromosome 9p21.3 |
RF |
|
C allele |
2011 |
19664850 |
| 2096 |
Alzheimer's Disease |
Human |
chromosome 9p21.3 |
RF |
|
in non-APOE epsilon4 |
2010 |
20427016 |
| 3227 |
Alzheimer's Disease |
Human |
CLECL1 |
RF |
|
|
2017 |
29177109 |
| 2969 |
Alzheimer's Disease |
Human |
CLU |
RF |
|
|
2016 |
26757186 |
| 1860 |
Alzheimer's Disease |
Human |
CLU |
RF |
|
Calculated by fixed effect model |
2018 |
29504051 |
| 502 |
Alzheimer's Disease |
Human |
CLU |
PF |
|
|
2016 |
26757186 |
| 1859 |
Alzheimer's Disease |
Human |
CLU |
RF |
|
Calculated by fixed effect model |
2018 |
29504051 |
| 2922 |
Alzheimer's Disease |
Human |
CLU |
RF |
Diagnosis |
|
2022 |
35135450 |
| 1856 |
Alzheimer's Disease |
Human |
CLU |
RF |
|
Calculated by random effect model |
2018 |
29504051 |
| 1858 |
Alzheimer's Disease |
Human |
CLU |
RF |
|
Calculated by fixed effect model |
2018 |
29504051 |
| 2072 |
Parkinson disease |
Human |
Clusterin (CLU) |
RF |
Diagnosis |
|
2021 |
33295114 |
| 2683 |
Alzheimer's Disease |
Human |
CNGB1 |
RF |
|
APOE-?2 |
2021 |
33576571 |
| 2410 |
Alzheimer's Disease |
Human |
CNGB1 |
RF |
|
APOE-?2 |
2021 |
33576571 |
| 2326 |
Alzheimer's Disease |
Human |
CNGB1 |
RF |
|
APOE-?2 |
2021 |
33576571 |
| 2684 |
Alzheimer's Disease |
Human |
CNGB1 |
RF |
|
APOE-?2 |
2021 |
33576571 |
| 2377 |
Tourette Syndrome |
Human |
CNR 1 |
RF |
|
|
2020 |
32194619 |
| 3767 |
Alzheimer's Disease |
Human |
CNR1 |
RF |
|
|
2021 |
33523009 |
| 2134 |
Dementia with Lewy bodies |
Human |
CNTN1 |
RF |
|
|
2018 |
29263008 |
| 2097 |
Amyotrophic Lateral Sclerosis |
Human |
CNTN4 |
RF |
Diagnosis |
|
2021 |
34421992 |
| 3564 |
Alzheimer's Disease |
Human |
coexistence of the APOE-ε4 allele and 3 SNPs in the BCHE gene |
RF |
|
|
2019 |
30914707 |
| 2324 |
Alzheimer's Disease |
Human |
COMT |
RF |
|
without APOE ε4 allele carriers |
2014 |
24575113 |
| 3005 |
Alzheimer's Disease |
Human |
COMT |
RF |
|
|
2021 |
33900525 |
| 2868 |
Alzheimer's Disease |
Human |
COMT |
RF |
|
|
2021 |
33900525 |
| 2228 |
Parkinson disease |
Human |
COMT |
RF |
|
|
1997 |
9503277 |
| 3002 |
Alzheimer's Disease |
Human |
COMT |
RF |
|
without APOE ε4 allele carriers;in men |
2014 |
24575113 |
| 465 |
Multiple System Atrophy |
Human |
COQ2 |
PF |
Diagnosis |
|
2022 |
35748722 |
| 3228 |
Multiple System Atrophy |
Human |
COQ2 |
RF |
|
|
2016 |
27123473 |
| 673 |
Alzheimer's Disease |
Human |
COX11 |
PF |
|
APOE-?2 |
2021 |
33576571 |
| 2125 |
Alzheimer's Disease |
Human |
COX-2 |
RF |
|
G allele |
2010 |
20110601 |
| 2100 |
Alzheimer's Disease |
Human |
COX-2 |
RF |
|
GG allele |
2010 |
20110601 |
| 2403 |
Alzheimer's Disease |
Human |
CPT1B |
RF |
|
APOE-?2 |
2021 |
33576571 |
| 1899 |
Alzheimer's Disease |
Human |
CR1 |
RF |
|
Calculated by fixed effect model |
2018 |
29504051 |
| 633 |
Alzheimer's Disease |
Human |
CR1 |
PF |
|
PENN cohort |
2018 |
30128317 |
| 1905 |
Alzheimer's Disease |
Human |
CR1 |
RF |
|
Calculated by fixed effect model |
2018 |
29504051 |
| 747 |
Alzheimer's Disease |
Human |
CR1 |
PF |
|
National Alzheimer’s Coordinating Center (NACC) cohort |
2018 |
30128317 |
| 1979 |
Alzheimer's Disease |
Human |
CR1 |
RF |
|
Calculated by fixed effect model |
2018 |
29504051 |
| 3077 |
Amyotrophic Lateral Sclerosis |
Human |
CREB3L2 |
RF |
|
|
2013 |
27455347 |
| 688 |
Alzheimer's Disease |
Human |
CRTC3 |
PF |
|
APOE-?2 |
2021 |
33576571 |
| 2206 |
Frontotemporal Lobar Degeneration |
Human |
CST3 |
RF |
|
negative for the presence of PGRN mutations;haplotype B |
2010 |
19674067 |
| 2532 |
Alzheimer's Disease |
Human |
CST3 |
RF |
|
Caucasians |
2000 |
10993992 |
| 2572 |
Alzheimer's Disease |
Human |
CST3 |
RF |
|
CST3-A allele; APOE ε4 carrier |
2001 |
11711204 |
| 3081 |
Alzheimer's Disease |
Human |
CST3 |
RF |
|
CST3-A allele; Non-APOE ε4 carrier |
2001 |
11711204 |
| 2257 |
Frontotemporal Lobar Degeneration |
Human |
CST3 |
RF |
|
negative for the presence of PGRN mutations;AB/BB genotypes |
2010 |
19674067 |
| 3229 |
Alzheimer's Disease |
Human |
CTNNA1 |
RF |
|
|
2017 |
29177109 |
| 2485 |
Alzheimer's Disease |
Human |
CTSB |
RF |
|
APOE-?2 |
2021 |
33576571 |
| 2632 |
Alzheimer's Disease |
Human |
CTSD |
RF |
|
|
2014 |
24281128 |
| 2424 |
Creutzfeldt-Jakob disease |
Human |
CTSD |
RF |
|
Genotype:CC |
2008 |
18426579 |
| 3122 |
Creutzfeldt-Jakob disease |
Human |
CTSD |
RF |
|
Genotype:CT |
2008 |
18426579 |
| 2362 |
Amyotrophic Lateral Sclerosis |
Human |
CX3CR1 |
RF |
|
|
2014 |
24806473 |
| 3230 |
Amyotrophic Lateral Sclerosis |
Human |
CX3CR1 |
RF |
|
|
2014 |
24806473 |
| 2651 |
Amyotrophic Lateral Sclerosis |
Human |
CX3CR1 |
RF |
|
|
2014 |
24806473 |
| 3732 |
Alzheimer's Disease |
Human |
CXCL12 |
RF |
|
|
2021 |
33687622 |
| 3232 |
Alzheimer's Disease |
Human |
CYP19A1 |
RF |
|
|
2016 |
27583919 |
| 2211 |
Alzheimer's Disease |
Human |
CYP2B6 |
RF |
|
APOE-?2 |
2021 |
33576571 |
| 1919 |
Alzheimer's Disease |
Human |
CYP2B6 |
RF |
|
APOE-?3 |
2021 |
33576571 |
| 3233 |
Alzheimer's Disease |
Human |
CYP2D6 |
RF |
|
CYP2D6B allele; in the Lewy body variant of AD |
1995 |
7818242 |
| 2710 |
Alzheimer's Disease |
Human |
CYP2J2 |
RF |
|
total;Genotype GT + TT |
2015 |
25796175 |
| 2687 |
Alzheimer's Disease |
Human |
CYP2J2 |
RF |
|
total;Allele T |
2015 |
25796175 |
| 2137 |
Alzheimer's Disease |
Human |
CYP46A1 |
RF |
|
Overall; Genotype:TT; dominant mode |
2018 |
29516283 |
| 3120 |
Alzheimer's Disease |
Human |
CYP46A1 |
RF |
|
APOE ε4 carrier; Genotype:CC |
2018 |
29516283 |
| 2688 |
Alzheimer's Disease |
Human |
CYP46A1 |
RF |
|
APOE ε4 carrier; Genotype:TT; dominant mode |
2018 |
29516283 |
| 3234 |
Alzheimer's Disease |
Human |
CYP46A1 |
RF |
|
CYP46A1 gene variations |
2009 |
19286353 |
| 2594 |
Alzheimer's Disease |
Human |
CYP46A1 |
RF |
|
APOE ε3/ε4; Genotype:CC; additive model |
2018 |
29516283 |
| 2259 |
Alzheimer's Disease |
Human |
CYP46A1 |
RF |
|
|
2012 |
22528464 |
| 2136 |
Alzheimer's Disease |
Human |
CYP46A1 |
RF |
|
Overall; Genotype:TC; logistic regression model |
2018 |
29516283 |
| 2665 |
Alzheimer's Disease |
Human |
CYP46A1 |
RF |
|
APOE ε3/ε4; Genotype:TT; dominant mode |
2018 |
29516283 |
| 2636 |
Alzheimer's Disease |
Human |
CYP46A1 |
RF |
|
APOE ε4 carrier; Genotype:CC; additive model |
2018 |
29516283 |
| 3790 |
Amyotrophic lateral sclerosis,Parkinson disease |
Human |
DAB1 |
RF |
Diagnosis |
|
2021 |
34707478 |
| 753 |
Alzheimer's Disease |
Human |
DAPK1 |
PF |
|
especially the homozygotes |
2011 |
21167819 |
| 2034 |
Alzheimer's Disease |
Human |
DAPK1 |
RF |
|
|
2011 |
21167819 |
| 3832 |
Parkinson disease |
Human |
DBH |
RF |
Prognosis |
|
2021 |
34945793 |
| 2459 |
Amyotrophic Lateral Sclerosis |
Human |
DCC |
RF |
|
|
2013 |
27455347 |
| 2920 |
Frontotemporal Lobar Degeneration |
Human |
DCUN1D1 |
RF |
|
Genotype:GG |
2009 |
19473369 |
| 629 |
Alzheimer's Disease |
Human |
DDIT4L |
PF |
|
APOE-?2 |
2021 |
33576571 |
| 1842 |
Parkinson disease |
Human |
DGCR8 |
RF |
|
|
2013 |
24018986 |
| 1841 |
Parkinson disease |
Human |
DGCR8 |
RF |
|
|
2013 |
24018986 |
| 1783 |
Alzheimer's Disease |
Human |
DHCR7 |
RF |
|
Chinese population |
2021 |
33692822 |
| 3789 |
Amyotrophic Lateral Sclerosis |
Human |
DHTKD1 |
RF |
Diagnosis |
|
2021 |
35052424 |
| 3235 |
Amyotrophic Lateral Sclerosis |
Human |
DISC1 |
RF |
|
|
2014 |
25023141 |
| 3724 |
Alzheimer's Disease |
Human |
DLD gene |
RF |
|
|
2021 |
33917565 |
| 2128 |
Parkinson disease |
Human |
DMRT2/SMARCA2 |
RF |
Diagnosis |
|
2021 |
33510632 |
| 2279 |
Parkinson disease |
Human |
DMT1 |
RF |
|
|
2011 |
21777657 |
| 3236 |
Parkinson disease |
Human |
DMT1 |
RF |
|
|
2015 |
25817364 |
| 2074 |
Parkinson disease |
Human |
DNA methylation (DNAm) CD56 |
RF |
Diagnosis |
|
2021 |
34768133 |
| 786 |
Parkinson disease |
Human |
DNA methylation (DNAm) EFEMP-1 |
PF |
Diagnosis |
|
2021 |
34768133 |
| 3109 |
Parkinson disease |
Human |
DNA Methylation cg10917602 site |
RF |
|
|
2016 |
27466229 |
| 892 |
Parkinson disease |
Human |
DOPA decarboxylase gene (DDC) |
PF |
Treatment |
|
2021 |
33051953 |
| 3237 |
Amyotrophic Lateral Sclerosis |
Human |
DPP6 |
RF |
|
|
2014 |
25023141 |
| 2621 |
Frontotemporal Lobar Degeneration |
Human |
DPP6 |
RF |
|
Discovery stage |
2019 |
30739198 |
| 693 |
Amyotrophic Lateral Sclerosis |
Human |
DPP6 |
PF |
Diagnosis |
|
2021 |
34421992 |
| 2627 |
Frontotemporal Lobar Degeneration |
Human |
DPP6 |
RF |
|
Discovery stage |
2019 |
30739198 |
| 2765 |
Amyotrophic Lateral Sclerosis |
Human |
DPYSL3(CRMP4) |
RF |
|
|
2013 |
23568759 |
| 504 |
Alzheimer's Disease |
Human |
DR4 |
PF |
|
GGC haplotype |
2013 |
25207117 |
| 581 |
Alzheimer's Disease |
Human |
DR4 |
PF |
|
ACA haplotype |
2013 |
25207117 |
| 830 |
Alzheimer's Disease |
Human |
DR4 |
PF |
|
the GA genotype |
2013 |
25207117 |
| 648 |
Alzheimer's Disease |
Human |
DR4 |
PF |
|
GGA haplotype |
2013 |
25207117 |
| 2076 |
Alzheimer's Disease |
Human |
DR4 |
RF |
|
GCA haplotype |
2013 |
25207117 |
| 2384 |
Alzheimer's Disease |
Human |
DR4 |
RF |
|
GCC haplotype |
2013 |
25207117 |
| 3834 |
Parkinson disease |
Human |
DRD2 |
RF |
Prognosis |
|
2021 |
34945793 |
| 3238 |
Tourette Syndrome |
Human |
DRD2 |
RF |
|
|
2010 |
20431429 |
| 779 |
Progressive Supranuclear Palsy |
Human |
DUSP10 |
PF |
|
Meta-analysis |
2018 |
29986742 |
| 2278 |
Parkinson disease |
Human |
DYRK1A |
RF |
|
especially for males |
2016 |
27546826 |
| 2038 |
Progressive Supranuclear Palsy |
Human |
EIF2AK3 |
RF |
Diagnosis |
|
2021 |
33897612 |
| 765 |
Progressive Supranuclear Palsy |
Human |
EIF2AK3 |
PF |
|
Meta-analysis |
2018 |
29986742 |
| 3239 |
Parkinson disease |
Human |
EMTP variation |
RF |
|
|
2019 |
30675927 |
| 2222 |
Alzheimer's Disease |
Human |
ENST00000414107 |
RF |
|
|
2018 |
29027019 |
| 549 |
Alzheimer's Disease |
Human |
EPHA7 |
PF |
|
APOE-?2 |
2021 |
33576571 |
| 2062 |
Alzheimer's Disease |
Human |
EPHA7 |
RF |
|
APOE-?3 |
2021 |
33576571 |
| 3240 |
Amyotrophic Lateral Sclerosis |
Human |
ERp57/PDIA3 |
RF |
|
|
2015 |
25913742 |
| 2239 |
Alzheimer's Disease |
Human |
ESR1 |
RF |
|
|
2012 |
20674091 |
| 653 |
Alzheimer's Disease |
Human |
ESR1 |
PF |
|
|
2012 |
20674091 |
| 1999 |
Alzheimer's Disease |
Human |
ESR1 |
RF |
|
|
2012 |
20674091 |
| 3017 |
Alzheimer's Disease |
Human |
ESR1 and ESR2 |
RF |
|
the genetic profile created with the combination of the less represented alleles of these SNPs (expressed as XPAA) |
2013 |
24052609 |
| 2372 |
Alzheimer's Disease |
Human |
ESR2 |
RF |
|
predominantly Caucasian AIMS-defined ancestry |
2014 |
24326520 |
| 2371 |
Alzheimer's Disease |
Human |
ESR2 |
RF |
|
predominantly Caucasian AIMS-defined ancestry |
2014 |
24326520 |
| 2195 |
Alzheimer's Disease |
Human |
ESR2 |
RF |
|
predominantly Caucasian AIMS-defined ancestry |
2014 |
24326520 |
| 2194 |
Alzheimer's Disease |
Human |
ESR2 |
RF |
|
predominantly Caucasian AIMS-defined ancestry |
2014 |
24326520 |
| 678 |
Alzheimer's Disease |
Human |
ESR3 |
PF |
|
|
2014 |
24326520 |
| 1925 |
Alzheimer's Disease |
Human |
EXOC3L2 |
RF |
|
|
2017 |
28423615 |
| 814 |
Alzheimer's Disease |
Human |
EXOC3L2 |
PF |
|
|
2017 |
28423615 |
| 3021 |
Alzheimer's Disease |
Human |
FAM107B |
RF |
|
APOE-?2 |
2021 |
33576571 |
| 703 |
Alzheimer's Disease |
Human |
FAM47E |
PF |
|
|
2021 |
33654092 |
| 2584 |
Alzheimer's Disease |
Human |
FAM71E2 |
RF |
|
APOE-?3 |
2021 |
33576571 |
| 2769 |
Parkinson disease |
Human |
Famliy history of familial Parkinson's disease |
RF |
|
|
2010 |
21059511 |
| 2444 |
Parkinson disease |
Human |
Famliy history of familial Parkinson's disease |
RF |
|
|
1996 |
8771062 |
| 3242 |
Parkinson disease |
Human |
FGF20 |
RF |
|
|
2012 |
22342445 |
| 1911 |
Parkinson disease |
Human |
FGF20 |
RF |
|
|
2014 |
24942208 |
| 3244 |
Parkinson disease |
Human |
FGF20 |
RF |
|
|
2004 |
15122513 |
| 3241 |
Parkinson disease |
Human |
FGF20 |
RF |
|
|
2015 |
26070653 |
| 3140 |
Parkinson disease |
Human |
FGF20 |
RF |
|
|
2015 |
26070653 |
| 3243 |
Parkinson disease |
Human |
FGF20 |
RF |
|
|
2004 |
15122513 |
| 2294 |
Alzheimer's Disease |
Human |
FOXN1 |
RF |
|
APOE-?2 |
2021 |
33576571 |
| 2246 |
Alzheimer's Disease |
Human |
FRMD4A |
RF |
|
|
2013 |
22430674 |
| 3245 |
Amyotrophic Lateral Sclerosis |
Human |
FUS |
RF |
|
|
2017 |
28054830 |
| 3759 |
Alzheimer's Disease |
Human |
FZD3 |
RF |
|
|
2021 |
32966694 |
| 2685 |
Alzheimer's Disease |
Human |
G-308A( TNF-alpha gene) |
RF |
|
A-allele |
2008 |
18992723 |
| 3097 |
Alzheimer's Disease |
Human |
GAB2 |
RF |
|
|
2011 |
21285854 |
| 792 |
Alzheimer's Disease |
Human |
GAB2 |
PF |
|
|
2015 |
26770425 |
| 3247 |
Alzheimer's Disease |
Human |
GAB2 |
RF |
|
|
2011 |
21285854 |
| 3246 |
Alzheimer's Disease |
Human |
GAB2 |
RF |
|
ApoE epsilon4 non-carriers |
2009 |
19276544 |
| 3127 |
Alzheimer's Disease |
Human |
GAB2 |
RF |
|
a minor genetic determinant of AD |
2008 |
18272374 |
| 2471 |
Alzheimer's Disease |
Human |
GAB2 |
RF |
|
|
2011 |
21285854 |
| 2032 |
Alzheimer's Disease |
Human |
GAB2 |
RF |
|
|
2011 |
21108942 |
| 3248 |
Alzheimer's Disease |
Human |
GAB2 |
RF |
|
|
2011 |
21285854 |
| 785 |
Alzheimer's Disease |
Human |
GAB2 |
PF |
|
|
2015 |
26770425 |
| 1923 |
Creutzfeldt-Jakob disease |
Human |
GAL3ST1 |
RF |
|
|
2020 |
32949544 |
| 3249 |
Alzheimer's Disease |
Human |
GALR3 |
RF |
|
|
2017 |
29177109 |
| 2518 |
Alzheimer's Disease |
Human |
GAMT |
RF |
|
APOE-?2 |
2021 |
33576571 |
| 2043 |
Alzheimer's Disease |
Human |
GAMT |
RF |
|
APOE-?3 |
2021 |
33576571 |
| 3250 |
Amyotrophic Lateral Sclerosis |
Human |
GARS |
RF |
|
|
2019 |
30661401 |
| 3063 |
Parkinson disease |
Human |
GBA |
RF |
|
|
2019 |
30765263 |
| 3255 |
Parkinson disease |
Human |
GBA |
RF |
|
strong risk factors in FPD, especially for autosomal dominant PD |
2014 |
24126159 |
| 3252 |
Dementia with Lewy bodies |
Human |
GBA |
RF |
|
|
2016 |
27312774 |
| 3800 |
Lewy Body Disease |
Human |
GBA |
RF |
|
|
2021 |
34308904 |
| 3257 |
Parkinson disease |
Human |
GBA |
RF |
|
|
2019 |
30765263 |
| 3096 |
Parkinson disease |
Human |
GBA |
RF |
|
|
2007 |
17702778 |
| 2647 |
Dementia with Lewy bodies |
Human |
GBA |
RF |
|
|
2018 |
29263008 |
| 3254 |
Parkinson disease |
Human |
GBA |
RF |
|
Patients with early-onset were more likely to carry GBA mutations than those with late-onset |
2016 |
26868973 |
| 3836 |
Parkinson disease |
Human |
GBA |
RF |
Diagnosis |
|
2021 |
34951095 |
| 3804 |
Lewy Body Disease |
Human |
GBA |
RF |
Diagnosis |
|
2021 |
33646158 |
| 3259 |
Dementia with Lewy bodies |
Human |
GBA |
RF |
|
|
2008 |
18332251 |
| 2990 |
Lewy Body Disease |
Human |
GBA |
RF |
Diagnosis |
|
2021 |
34308904 |
| 2944 |
Parkinson disease |
Human |
GBA |
RF |
|
|
2013 |
22812582 |
| 3251 |
Dementia with Lewy bodies |
Human |
GBA |
RF |
|
|
2016 |
27723861 |
| 3099 |
Parkinson disease |
Human |
GBA |
RF |
|
|
2010 |
20131388 |
| 3256 |
Parkinson disease |
Human |
GBA |
RF |
|
|
2016 |
26000814 |
| 1658 |
Parkinson disease |
Human |
GBA |
RF |
Prognosis |
|
2023 |
36348503 |
| 3253 |
Dementia with Lewy bodies |
Human |
GBA |
RF |
|
|
2016 |
27027900 |
| 3258 |
Parkinson disease |
Human |
GBA |
RF |
|
|
2019 |
30765263 |
| 2767 |
Parkinson disease |
Human |
GBA |
RF |
|
|
2012 |
22387070 |
| 2773 |
Parkinson disease |
Human |
GBA1 |
RF |
|
non-N370S mutations associated with Gaucher disease |
2013 |
22968580 |
| 1838 |
Parkinson disease |
Human |
GBA1 |
RF |
Diagnosis |
|
2022 |
37633302 |
| 2179 |
Parkinson disease |
Human |
GBA1 |
RF |
Diagnosis |
|
2022 |
37633302 |
| 3095 |
Dementia with Lewy bodies |
Human |
GBA1 |
RF |
|
|
2013 |
23588557 |
| 898 |
Parkinson disease |
Human |
GCase gene therapy |
PF |
|
|
2021 |
34062940 |
| 3260 |
Parkinson disease |
Human |
GCH1 |
RF |
|
|
2017 |
27871051 |
| 2293 |
Alzheimer's Disease |
Human |
GCH1 |
RF |
|
|
2018 |
29432188 |
| 1989 |
Parkinson disease |
Human |
GLIS1 |
RF |
|
|
2012 |
22759478 |
| 3761 |
Alzheimer's Disease |
Human |
GOLGA8B |
RF |
|
|
2021 |
32966694 |
| 2065 |
Alzheimer's Disease |
Human |
GOLPH2 |
RF |
|
|
2012 |
22167654 |
| 2066 |
Alzheimer's Disease |
Human |
GOLPH2 |
RF |
|
|
2012 |
22167654 |
| 3107 |
Alzheimer's Disease |
Human |
GORASP2 |
RF |
|
APOE-?2 |
2021 |
33576571 |
| 2737 |
Parkinson disease |
Human |
GP1BA |
RF |
|
|
2020 |
33021140 |
| 2213 |
Parkinson disease |
Human |
GP6 |
RF |
|
|
2020 |
33021140 |
| 601 |
Alzheimer's Disease |
Human |
GPIHBP1 |
PF |
|
APOE-?2 |
2021 |
33576571 |
| 3047 |
Alzheimer's Disease |
Human |
GPR37 |
RF |
|
APOE-?2 |
2021 |
33576571 |
| 3261 |
Parkinson disease |
Human |
GRIN2A |
RF |
|
taking creatine who also have high levels of caffeine intake |
2017 |
28320167 |
| 3262 |
Parkinson disease |
Human |
GRIN2A T allele |
RF |
|
taking creatine who also have high levels of caffeine intake |
2017 |
28320167 |
| 1489 |
Frontotemporal Dementia |
Human |
GRN |
RF |
Diagnosis |
|
2021 |
32972771 |
| 3671 |
Frontotemporal Lobar Degeneration |
Human |
GRN |
RF |
|
FTLD with TAR DNA-binding protein (TDP-43) inclusions |
2010 |
20154673 |
| 1934 |
Alzheimer's Disease |
Human |
GRN |
RF |
|
|
2017 |
26820675 |
| 2808 |
Frontotemporal Lobar Degeneration |
Human |
GRN |
RF |
|
Genotype:TT |
2008 |
18723524 |
| 3815 |
Lewy Body Disease |
Human |
GRN |
RF |
Diagnosis |
|
2021 |
34854996 |
| 3263 |
Frontotemporal Lobar Degeneration |
Human |
GRN |
RF |
|
|
2014 |
24503614 |
| 2219 |
Frontotemporal Lobar Degeneration |
Human |
GRN |
RF |
|
more common (T) allele |
2010 |
20154673 |
| 3018 |
Alzheimer's Disease |
Human |
GSN |
RF |
|
APOE-?2 |
2021 |
33576571 |
| 2498 |
Alzheimer's Disease |
Human |
GSTM1 |
RF |
|
|
2012 |
22381228 |
| 2905 |
Parkinson disease |
Human |
GSTM1 |
RF |
Diagnosis |
|
2021 |
32359946 |
| 2867 |
Alzheimer's Disease |
Human |
GSTM1 |
RF |
|
|
2018 |
29072550 |
| 2772 |
Parkinson disease |
Human |
GSTM1/T1 null genotypes |
RF |
Diagnosis |
|
2021 |
32359946 |
| 3264 |
Alzheimer's Disease |
Human |
GSTP1 |
RF |
|
mainly in the presence of the apoE 4 allele |
2008 |
18298341 |
| 2225 |
Alzheimer's Disease |
Human |
GSTT1 |
RF |
|
|
2018 |
29072550 |
| 3032 |
Parkinson disease |
Human |
GSTT1 |
RF |
Diagnosis |
|
2021 |
32359946 |
| 1412 |
Amyotrophic Lateral Sclerosis |
Human |
H63D |
RF |
|
|
2020 |
33070529 |
| 591 |
Alzheimer's Disease |
Human |
HAP1 |
PF |
|
APOE-?3 |
2021 |
33576571 |
| 587 |
Alzheimer's Disease |
Human |
HAP1 |
PF |
|
APOE-?3 |
2021 |
33576571 |
| 3265 |
Alzheimer's Disease |
Human |
hemochromatosis (HFE) |
RF |
|
|
2014 |
27081498 |
| 683 |
Parkinson disease |
Human |
HFE |
PF |
|
Australian PD patients |
2002 |
12098643 |
| 2798 |
Amyotrophic Lateral Sclerosis |
Human |
HFE |
RF |
|
Genotype:GC |
2011 |
20642794 |
| 2845 |
Amyotrophic Lateral Sclerosis |
Human |
HFE |
RF |
|
Genotype:GC/GG |
2011 |
20642794 |
| 3267 |
Parkinson disease |
Human |
HFE |
RF |
|
|
2006 |
16824219 |
| 2874 |
Amyotrophic Lateral Sclerosis |
Human |
HFE |
RF |
|
Genotype:G allele frequency |
2011 |
20642794 |
| 684 |
Parkinson disease |
Human |
HFE |
PF |
|
Australian PD patients |
2002 |
12098643 |
| 3266 |
Parkinson disease |
Human |
HFE |
RF |
|
|
2006 |
16824219 |
| 3268 |
Alzheimer's Disease |
Human |
HIF3A |
RF |
|
eQTL(expression quantitative trait loci) analysis for the five SNPs closely related to AD |
2018 |
30319691 |
| 1437 |
Alzheimer's Disease |
Human |
HLA-A24 |
RF |
|
|
2008 |
18936542 |
| 2486 |
Frontotemporal Lobar Degeneration |
Human |
HLA-DQA2 |
RF |
|
Discovery stage |
2019 |
30739198 |
| 2338 |
Frontotemporal Lobar Degeneration |
Human |
HLA-DQA2 |
RF |
|
Replication stage |
2019 |
30739198 |
| 3269 |
Parkinson disease |
Human |
HLA-DRA |
RF |
|
|
2014 |
25319953 |
| 2738 |
Amyotrophic Lateral Sclerosis |
Human |
HLA-DRA/HLA-DRB5 |
RF |
|
the AA genotype at rs9268856 |
2017 |
28131168 |
| 1931 |
Alzheimer's Disease |
Human |
HLA-DRB1 |
RF |
|
non-APOE ε4 carriers with rs9271192 genotype CC;additive model |
2017 |
29190991 |
| 2488 |
Alzheimer's Disease |
Human |
HLA-DRB1 |
RF |
|
under a recessive model in the total sample |
2017 |
29190991 |
| 2667 |
Alzheimer's Disease |
Human |
HLA-DRB1 |
RF |
|
non-APOE ε4 carriers with rs9271192 genotype CC;recessive model |
2017 |
29190991 |
| 533 |
Frontotemporal Lobar Degeneration |
Human |
HMCN1 |
PF |
|
Discovery stage |
2019 |
30739198 |
| 2597 |
Frontotemporal Lobar Degeneration |
Human |
hnRNP-A1 |
RF |
|
C/C genotype |
2011 |
21548758 |
| 2217 |
Frontotemporal Lobar Degeneration |
Human |
hnRNP-A1 |
RF |
|
C/C genotype |
2011 |
21548758 |
| 554 |
Alzheimer's Disease |
Human |
HSP70/HSPA1A |
PF |
|
Genotype: A/C; AD without depression |
2018 |
29703883 |
| 2934 |
Alzheimer's Disease |
Human |
Ig γ marker (GM) allotypes |
RF |
|
encoded by highly polymorphic IGHG genes on chromosome 14q32 |
2020 |
32709662 |
| 2628 |
Alzheimer's Disease |
Human |
IGFALS |
RF |
|
APOE-?3 |
2021 |
33576571 |
| 2063 |
Alzheimer's Disease |
Human |
IL-1 beta promoter polymorphism |
RF |
|
APOE4 presence:No stratified |
2008 |
18717723 |
| 2691 |
Alzheimer's Disease |
Human |
IL-1 beta promoter polymorphism |
RF |
|
APOE4 presence:APOE4 yes |
2008 |
18717723 |
| 2205 |
Alzheimer's Disease |
Human |
IL-1 beta promoter polymorphism |
RF |
|
APOE4 presence:APOE4 no |
2008 |
18717723 |
| 3270 |
Alzheimer's Disease |
Human |
IL-1 genes cluster |
RF |
|
|
2012 |
22498095 |
| 831 |
Alzheimer's Disease |
Human |
IL-1 genes cluster |
PF |
|
|
2012 |
22498095 |
| 3272 |
Parkinson disease |
Human |
IL-10 |
RF |
|
|
2012 |
22387064 |
| 3271 |
Parkinson disease |
Human |
IL-10 |
RF |
|
|
2012 |
21241672 |
| 3273 |
Parkinson disease |
Human |
IL-18 |
RF |
|
|
2012 |
21241672 |
| 3275 |
Alzheimer's Disease |
Human |
IL-1B |
RF |
|
|
2017 |
26768592 |
| 3274 |
Alzheimer's Disease |
Human |
IL-1B |
RF |
|
|
2017 |
26768592 |
| 3276 |
Alzheimer's Disease |
Human |
IL-1α |
RF |
|
|
2016 |
27014584 |
| 3277 |
Multiple System Atrophy |
Human |
IL-1β |
RF |
|
|
2018 |
29251119 |
| 2201 |
Frontotemporal Lobar Degeneration |
Human |
IMMP2L |
RF |
|
Discovery stage |
2019 |
30739198 |
| 628 |
Alzheimer's Disease |
Human |
INO80D |
PF |
|
APOE-?2 |
2021 |
33576571 |
| 2764 |
Amyotrophic Lateral Sclerosis |
Human |
INPP5B |
RF |
Diagnosis |
|
2021 |
34421992 |
| 3738 |
Alzheimer's Disease |
mice |
INPP5D |
RF |
|
|
2021 |
33631273 |
| 2280 |
Alzheimer's Disease |
Human |
insulin degrading enzyme gene (IDE) |
RF |
|
|
2012 |
20880607 |
| 2997 |
Alzheimer's Disease |
Human |
insulin degrading enzyme gene (IDE) |
RF |
|
CC genotype was significantly associated with earlier age at onset |
2012 |
20880607 |
| 2832 |
Amyotrophic Lateral Sclerosis |
Human |
Intergenic |
RF |
|
The estimations using the proposed method (unadjusted estimates) |
2009 |
19740415 |
| 2787 |
Amyotrophic Lateral Sclerosis |
Human |
Intergenic |
RF |
|
The estimations using the proposed method (adjusted estimates) |
2009 |
19740415 |
| 2880 |
Amyotrophic Lateral Sclerosis |
Human |
Intergenic and SHROOM3 |
RF |
|
The estimations using the proposed method (unadjusted estimates) |
2009 |
19740415 |
| 2838 |
Amyotrophic Lateral Sclerosis |
Human |
Intergenic and SHROOM4 |
RF |
|
The estimations using the proposed method (adjusted estimates) |
2009 |
19740415 |
| 3028 |
Amyotrophic Lateral Sclerosis |
Human |
intermediate-length alleles when present in both alleles |
RF |
|
Carriership of two intermediate-length alleles was associated with ALS, when the longer allele was ≥ 17 repeats |
2020 |
33168078 |
| 2448 |
Amyotrophic Lateral Sclerosis |
Human |
intermediate-length alleles when present in both alleles |
RF |
|
Carriership of two intermediate-length alleles was associated with ALS, when the longer allele was ≥ 21 repeats |
2020 |
33168078 |
| 696 |
Frontotemporal Lobar Degeneration |
Human |
IRF2 |
PF |
|
Discovery stage |
2019 |
30739198 |
| 1932 |
Alzheimer's Disease |
Human |
ITGA2B |
RF |
|
APOE-?3 |
2021 |
33576571 |
| 2256 |
Alzheimer's Disease |
Human |
ITGA4 |
RF |
|
Dominant; Genotype/Allele: AG+GG; Multivariate analysis |
2018 |
29769839 |
| 2242 |
Alzheimer's Disease |
Human |
ITGA4 |
RF |
|
Overdominant; Genotype/Allele: AG; Multivariate analysis |
2018 |
29769839 |
| 2360 |
Alzheimer's Disease |
Human |
ITGA4 |
RF |
|
Codominant; Genotype/Allele: AG; Univariate analysis |
2018 |
29769839 |
| 2302 |
Alzheimer's Disease |
Human |
ITGA4 |
RF |
|
Dominant; Genotype/Allele: AG+GG; Univariate analysis |
2018 |
29769839 |
| 2334 |
Alzheimer's Disease |
Human |
ITGA4 |
RF |
|
Overdominant; Genotype/Allele: AG; Univariate analysis |
2018 |
29769839 |
| 1970 |
Parkinson disease |
Human |
ITGB5 |
RF |
|
|
2020 |
33021140 |
| 3278 |
Amyotrophic Lateral Sclerosis |
Human |
ITPR2 |
RF |
|
|
2014 |
25023141 |
| 2181 |
Alzheimer's Disease |
Human |
KCNJ15 |
RF |
|
|
2018 |
29432188 |
| 574 |
Alzheimer's Disease |
Human |
KIBRA |
PF |
|
|
2013 |
24190487 |
| 3810 |
Lewy Body Disease |
Human |
KIF17 |
RF |
Diagnosis |
|
2021 |
34124335 |
| 3078 |
Amyotrophic Lateral Sclerosis |
Human |
KIF5A |
RF |
|
|
2013 |
27455347 |
| 3124 |
Alzheimer's Disease |
Human |
LAMA2 |
RF |
|
APOE-?3 |
2021 |
33576571 |
| 2215 |
Alzheimer's Disease |
Human |
LAMA2 |
RF |
|
APOE-?2 |
2021 |
33576571 |
| 535 |
Alzheimer's Disease |
Human |
LAMA2 |
PF |
|
APOE-?2 |
2021 |
33576571 |
| 3279 |
Alzheimer's Disease |
Human |
LCORL |
RF |
|
|
2018 |
29860282 |
| 2108 |
Alzheimer's Disease |
Human |
LDLR |
RF |
|
|
2008 |
18065781 |
| 489 |
Alzheimer's Disease |
Human |
LHCGR |
PF |
|
carrying an APOE epsilon4 allele |
2008 |
18439297 |
| 2091 |
Alzheimer's Disease |
Human |
LOC100505811 |
RF |
|
|
2018 |
29027019 |
| 2183 |
Alzheimer's Disease |
Human |
LOC100505811 |
RF |
|
|
2018 |
29027019 |
| 2149 |
Alzheimer's Disease |
Human |
LOC100505811 |
RF |
|
|
2018 |
29027019 |
| 2180 |
Alzheimer's Disease |
Human |
LOC100505811 |
RF |
|
|
2018 |
29027019 |
| 2105 |
Frontotemporal Lobar Degeneration |
Human |
LOC101927354 |
RF |
|
Discovery stage |
2019 |
30739198 |
| 2061 |
Amyotrophic Lateral Sclerosis |
Human |
LOC107987057 |
RF |
|
|
2010 |
20801717 |
| 1960 |
Amyotrophic Lateral Sclerosis |
Human |
LOC107987057 |
RF |
|
In the joint analysis |
2010 |
20801717 |
| 2526 |
Amyotrophic Lateral Sclerosis |
Human |
LOC107987057 |
RF |
|
|
2010 |
20801718 |
| 2057 |
Amyotrophic Lateral Sclerosis |
Human |
LOC107987057,LOC112268043 |
RF |
|
|
2010 |
20801717 |
| 1961 |
Amyotrophic Lateral Sclerosis |
Human |
LOC107987057,LOC112268043 |
RF |
|
In the joint analysis |
2010 |
20801717 |
| 2520 |
Amyotrophic Lateral Sclerosis |
Human |
LOC112268043,LOC107987057 |
RF |
|
|
2010 |
20801718 |
| 2418 |
Alzheimer's Disease |
Human |
LPA |
RF |
|
APOE-?2 |
2021 |
33576571 |
| 3775 |
Amyotrophic Lateral Sclerosis |
Human |
LRP10 |
RF |
|
|
2021 |
32690342 |
| 2052 |
Alzheimer's Disease |
Human |
LRP2 |
RF |
|
|
2011 |
20971101 |
| 783 |
Alzheimer's Disease |
Human |
LRRC17 |
PF |
|
APOE-?3 |
2021 |
33576571 |
| 656 |
Alzheimer's Disease |
Human |
LRRC17 |
PF |
|
APOE-?2 |
2021 |
33576571 |
| 2005 |
Alzheimer's Disease |
Human |
LRRC17 |
RF |
|
APOE-?3 |
2021 |
33576571 |
| 2098 |
Alzheimer's Disease |
Human |
LRRC2 |
RF |
|
APOE-?2 |
2021 |
33576571 |
| 3112 |
Parkinson disease |
Human |
LRRK2 |
RF |
|
reater frequency of the G2019S mutation in Jewish than in non-Jewish cases with Parkinson disease |
2006 |
17050822 |
| 805 |
Parkinson disease |
Human |
LRRK2 |
PF |
|
|
2012 |
23115130 |
| 2981 |
Parkinson disease |
Human |
LRRK2 |
RF |
|
|
2013 |
23624603 |
| 3855 |
Parkinson disease |
Human |
LRRK2 |
RF |
|
|
2021 |
34060004 |
| 1941 |
Parkinson disease |
Human |
LRRK2 |
RF |
|
|
2012 |
23115130 |
| 3872 |
Parkinson disease |
Human |
LRRK2 |
RF |
Diagnosis |
|
2021 |
33742109 |
| 3141 |
Parkinson disease |
Human |
LRRK2 |
RF |
|
|
2009 |
19699188 |
| 3280 |
Multiple System Atrophy |
Human |
LRRK2 |
RF |
|
|
2018 |
29480226 |
| 3711 |
Alzheimer's Disease |
Human |
LRRK2 |
RF |
|
|
2021 |
34135785 |
| 2514 |
Parkinson disease |
Human |
LRRK2 |
RF |
|
|
2008 |
18716801 |
| 3282 |
Parkinson disease |
Human |
LRRK2 |
RF |
|
|
2007 |
17960808 |
| 2682 |
Parkinson disease |
Human |
LRRK2 |
RF |
|
|
2007 |
17314670 |
| 2904 |
Parkinson disease |
Human |
LRRK2 |
RF |
|
|
2008 |
18201193 |
| 2335 |
Parkinson disease |
Human |
LRRK2 |
RF |
|
|
2010 |
19854095 |
| 2504 |
Parkinson disease |
Human |
LRRK2 |
RF |
|
|
2007 |
17019612 |
| 2511 |
Parkinson disease |
Human |
LRRK2 |
RF |
|
especially in early-onset patients |
2015 |
26234753 |
| 2888 |
Parkinson disease |
Human |
LRRK2 |
RF |
|
|
2009 |
19672984 |
| 2487 |
Parkinson disease |
Human |
LRRK2 |
RF |
|
|
2010 |
20673920 |
| 2548 |
Parkinson disease |
Human |
LRRK2 |
RF |
|
|
2006 |
16633828 |
| 3874 |
Parkinson disease |
Human |
LRRK2 |
RF |
Diagnosis |
|
2021 |
33574311 |
| 1719 |
Parkinson disease |
Human |
LRRK2 |
RF |
Diagnosis |
|
2023 |
35733392 |
| 3281 |
Parkinson disease |
Human |
LRRK2 |
RF |
|
|
2011 |
21167764 |
| 2327 |
Parkinson disease |
Human |
LRRK2 |
RF |
|
|
2011 |
20629711 |
| 2801 |
Alzheimer's Disease |
Human |
LTBP1 |
RF |
|
APOE-?2 |
2021 |
33576571 |
| 2800 |
Alzheimer's Disease |
Human |
LTBP1 |
RF |
|
APOE-?2 |
2021 |
33576571 |
| 631 |
Alzheimer's Disease |
Human |
LTBP1 |
PF |
|
APOE-?3 |
2021 |
33576571 |
| 2491 |
Amyotrophic Lateral Sclerosis |
Human |
M1(C/C) |
RF |
|
|
2007 |
17503480 |
| 555 |
Amyotrophic Lateral Sclerosis |
Human |
M5(A/A) |
PF |
|
|
2007 |
17503480 |
| 2908 |
Amyotrophic Lateral Sclerosis |
Human |
M6(T/T) |
RF |
|
|
2007 |
17503480 |
| 3283 |
Parkinson disease |
Human |
MAO |
RF |
|
|
1994 |
7913737 |
| 3284 |
Parkinson disease |
Human |
MAO |
RF |
|
|
1994 |
7913737 |
| 2379 |
Multiple System Atrophy |
Human |
MAPT |
RF |
|
H1 haplotype |
2011 |
21321341 |
| 2783 |
Frontotemporal Lobar Degeneration |
Human |
MAPT |
RF |
|
|
2012 |
22556362 |
| 2079 |
Parkinson disease |
Human |
MAPT |
RF |
|
|
2005 |
15627775 |
| 3049 |
Frontotemporal Lobar Degeneration |
Human |
MAPT |
RF |
|
H2H2 vs. H1H2 + H1H1 |
2006 |
16410051 |
| 498 |
Progressive Supranuclear Palsy |
Human |
MAPT |
PF |
Diagnosis |
|
2021 |
33897612 |
| 618 |
Progressive Supranuclear Palsy |
Human |
MAPT |
PF |
|
Meta-analysis |
2018 |
29986742 |
| 3985 |
Amyotrophic Lateral Sclerosis |
Human |
MAPT |
RF |
Diagnosis |
|
2023 |
38002967 |
| 3285 |
Frontotemporal Dementia |
Human |
MAPT |
RF |
|
a rare microtubule-associated protein tau (MAPT) sequence variant, c.454G>A (p.A152T) |
2013 |
23518664 |
| 2782 |
Frontotemporal Dementia |
Human |
MAPT |
RF |
|
|
2012 |
22556362 |
| 3037 |
Progressive Supranuclear Palsy |
Human |
MAPT |
RF |
|
Meta-analysis |
2018 |
29986742 |
| 2582 |
Progressive Supranuclear Palsy |
Human |
MAPT |
RF |
Diagnosis |
|
2021 |
33897612 |
| 3135 |
Parkinson disease |
Human |
MAPT |
RF |
|
|
2010 |
19912324 |
| 2568 |
Alzheimer's Disease |
Human |
MAPT |
RF |
|
|
2012 |
22556362 |
| 2332 |
Frontotemporal Dementia |
Human |
MAPT H2 haplotype |
RF |
|
|
2006 |
16410051 |
| 2746 |
Frontotemporal Dementia |
Human |
MAPT H2 haplotype |
RF |
|
APOE e4 negatives |
2006 |
16410051 |
| 2437 |
Frontotemporal Dementia |
Human |
MAPT H2H3 genetype |
RF |
|
APOE e4 negatives |
2006 |
16410051 |
| 3287 |
Parkinson disease |
Human |
MC1R |
RF |
|
|
2009 |
19194882 |
| 2411 |
Alzheimer's Disease |
Human |
MC1R |
RF |
|
|
2017 |
28059796 |
| 3286 |
Parkinson disease |
Human |
MC1R |
RF |
|
|
2009 |
19194882 |
| 3712 |
Alzheimer's Disease |
Human |
MEF2C |
RF |
|
|
2021 |
34163341 |
| 3288 |
Frontotemporal Lobar Degeneration |
Human |
MFSD8 |
RF |
|
|
2019 |
30382371 |
| 3776 |
Amyotrophic Lateral Sclerosis |
Human |
MFSD8 |
RF |
Diagnosis |
|
2021 |
33226711 |
| 3665 |
Amyotrophic Lateral Sclerosis |
Human |
MFSD8 |
RF |
|
|
2021 |
33226711 |
| 3048 |
Alzheimer's Disease |
Human |
MGME1 |
RF |
|
APOE-?2 |
2021 |
33576571 |
| 573 |
Alzheimer's Disease |
Human |
MIA2 |
PF |
|
APOE-?3 |
2021 |
33576571 |
| 768 |
Alzheimer's Disease |
Human |
MIA2 |
PF |
|
APOE-?3 |
2021 |
33576571 |
| 796 |
Alzheimer's Disease |
Human |
microtubule-associated protein tau (MAPT) gene |
PF |
|
individuals with a GG genotype of rs242557G/A |
2018 |
29098924 |
| 3289 |
Alzheimer's Disease |
Human |
MIEF1 |
RF |
|
|
2017 |
29177109 |
| 2129 |
Frontotemporal Lobar Degeneration |
Human |
MIR548AP |
RF |
|
Discovery stage |
2019 |
30739198 |
| 3290 |
Alzheimer's Disease |
Human |
MLKL |
RF |
|
MLKL loss-of-function mutation |
2018 |
29656768 |
| 3291 |
Amyotrophic Lateral Sclerosis |
Human |
MOB3B |
RF |
|
|
2014 |
25023141 |
| 2554 |
Amyotrophic Lateral Sclerosis |
Human |
MOB3B |
RF |
|
|
2010 |
20801718 |
| 715 |
Progressive Supranuclear Palsy |
Human |
MOBP |
PF |
|
Meta-analysis |
2018 |
29986742 |
| 3786 |
Amyotrophic Lateral Sclerosis |
Human |
MOBP |
RF |
Diagnosis |
Greece |
2021 |
34694630 |
| 2840 |
Parkinson disease |
Human |
Monoamine oxidase-B (MAO-B) |
RF |
|
levodopa-induced dyskinesia(LID) |
2020 |
32346620 |
| 3292 |
Alzheimer's Disease |
Human |
mosaic aneuploidy in the brain |
RF |
|
|
2014 |
24602248 |
| 1888 |
Alzheimer's Disease |
Human |
MS4A4E |
RF |
|
|
2015 |
26770425 |
| 3293 |
Alzheimer's Disease |
Human |
MS4A6A |
RF |
|
|
2012 |
22382309 |
| 1857 |
Alzheimer's Disease |
Human |
MS4A6A |
RF |
|
Calculated by fixed effect model |
2018 |
29504051 |
| 1862 |
Alzheimer's Disease |
Human |
MS4A6A |
RF |
|
Calculated by fixed effect model |
2018 |
29504051 |
| 802 |
Alzheimer's Disease |
Human |
MS4A6A |
PF |
|
|
2015 |
26770425 |
| 1861 |
Alzheimer's Disease |
Human |
MS4A6A |
RF |
|
Calculated by fixed effect model |
2018 |
29504051 |
| 2331 |
Alzheimer's Disease |
Human |
MTHFD1L |
RF |
|
the results were influenced by APOE status |
2011 |
21741665 |
| 1992 |
Alzheimer's Disease |
Human |
MTHFR |
RF |
|
without APOE epsilon4 alleles |
2010 |
20600372 |
| 1937 |
Alzheimer's Disease |
Human |
MTHFR |
RF |
|
in APOE?4 or in non-APOE?4 carriers |
2017 |
28211809 |
| 2771 |
Alzheimer's Disease |
Human |
MTHFR |
RF |
|
AA genotype |
2013 |
23659764 |
| 3294 |
Alzheimer's Disease |
Human |
MTHFR |
RF |
|
increased the odds of developing AD by 2.5 |
2012 |
22015309 |
| 2648 |
Amyotrophic Lateral Sclerosis |
Human |
MTHFR(T677T) |
RF |
|
|
2012 |
22385294 |
| 2748 |
Amyotrophic Lateral Sclerosis |
Human |
MTHFR(T677T/A1298A) |
RF |
|
|
2012 |
22385294 |
| 2749 |
Amyotrophic Lateral Sclerosis |
Human |
MTHFR(T677T/A1298A) |
RF |
|
|
2012 |
22385294 |
| 3295 |
Alzheimer's Disease |
Human |
MTNR1A |
RF |
|
|
2018 |
29982836 |
| 3844 |
Parkinson disease |
Human |
MTPAP |
RF |
|
|
2021 |
34394198 |
| 2639 |
Parkinson disease |
Human |
MUL1 |
RF |
Diagnosis |
|
2021 |
34946922 |
| 3480 |
Tuberous sclerosis complex |
Human |
mutations in TSC2 |
RF |
|
|
2015 |
26631248 |
| 3773 |
Alzheimer's Disease |
mice |
MUTYH |
RF |
Treatment |
|
2021 |
34970419 |
| 2402 |
Alzheimer's Disease |
Human |
MYEOV |
RF |
|
APOE-?2 |
2021 |
33576571 |
| 3758 |
Alzheimer's Disease |
Human |
MYH11 |
RF |
|
|
2021 |
32966694 |
| 3296 |
Motor Neuron Disease |
Human |
NEFH |
RF |
|
Genotype: SS |
2004 |
14722583 |
| 3094 |
Amyotrophic Lateral Sclerosis |
Human |
NEK1 |
RF |
|
|
2013 |
27455347 |
| 2614 |
Amyotrophic Lateral Sclerosis |
Human |
NEK1 |
RF |
|
|
2013 |
27455347 |
| 2613 |
Amyotrophic Lateral Sclerosis |
Human |
NEK1 |
RF |
|
|
2013 |
27455347 |
| 2689 |
Amyotrophic Lateral Sclerosis |
Human |
NEK1 |
RF |
|
|
2013 |
27455347 |
| 2071 |
Alzheimer's Disease |
Human |
NEP gene (MME) |
RF |
|
|
2012 |
22493749 |
| 1330 |
Alzheimer's Disease |
Human |
neprilysin (NEP) |
RF |
|
|
2010 |
20376800 |
| 541 |
Alzheimer's Disease |
Human |
NINJ2 |
PF |
|
|
2011 |
21674003 |
| 537 |
Alzheimer's Disease |
Human |
NINJ2 |
PF |
|
|
2011 |
21674003 |
| 575 |
Alzheimer's Disease |
Human |
NINJ2 |
PF |
|
|
2011 |
21674003 |
| 3297 |
Amyotrophic Lateral Sclerosis |
Human |
NIPA1 |
RF |
|
|
2012 |
22378146 |
| 3298 |
Parkinson disease |
Human |
NOD2 |
RF |
|
associated with late-onset PD |
2013 |
23651603 |
| 762 |
Alzheimer's Disease |
Human |
NOP56 |
PF |
|
APOE-?3 |
2021 |
33576571 |
| 672 |
Alzheimer's Disease |
Human |
NOP56 |
PF |
|
APOE-?2 |
2021 |
33576571 |
| 1333 |
Alzheimer's Disease |
Human |
NOS3 |
RF |
|
in the APOE epsilon 4 noncarriers |
2008 |
18183499 |
| 2226 |
Frontotemporal Lobar Degeneration |
Human |
NOS3 |
RF |
|
|
2009 |
19087148 |
| 1332 |
Alzheimer's Disease |
Human |
NOS3 |
RF |
|
in the APOE epsilon 4 noncarriers |
2008 |
18183499 |
| 3299 |
Alzheimer's Disease |
Human |
NOS3 |
RF |
|
|
2010 |
20505439 |
| 1966 |
Alzheimer's Disease |
Human |
NQO1 |
RF |
|
|
2008 |
18253865 |
| 711 |
Alzheimer's Disease |
Human |
NQO1 |
PF |
|
significant difference in the APOE epsilon4 non-carriers |
2008 |
18253865 |
| 2304 |
Alzheimer's Disease |
Human |
NT-3 |
RF |
|
homozygotes or heterozygotes for the mutated type (Glu[-63]) |
1998 |
9502217 |
| 599 |
Alzheimer's Disease |
Human |
NTF-3 |
PF |
|
in patients lacking the ApoE-?4 allele |
2015 |
26814132 |
| 2652 |
Alzheimer's Disease |
Human |
NUMA1 |
RF |
|
APOE-?2 |
2021 |
33576571 |
| 2626 |
Alzheimer's Disease |
Human |
NUMA1 |
RF |
|
APOE-?2 |
2021 |
33576571 |
| 2287 |
Frontotemporal Lobar Degeneration |
Human |
OLFM1 |
RF |
|
Discovery stage |
2019 |
30739198 |
| 3085 |
Parkinson disease |
Human |
Omi/HTRA2 |
RF |
|
|
2011 |
21338583 |
| 2475 |
Alzheimer's Disease |
Human |
OPRD1 |
RF |
|
APOE-?2 |
2021 |
33576571 |
| 2286 |
Alzheimer's Disease |
Human |
OPRD1 |
RF |
|
APOE-?3 |
2021 |
33576571 |
| 2216 |
Alzheimer's Disease |
Human |
OR1S2 |
RF |
|
APOE-?2 |
2021 |
33576571 |
| 2273 |
Alzheimer's Disease |
Human |
OR1S2 |
RF |
|
APOE-?2 |
2021 |
33576571 |
| 2036 |
Alzheimer's Disease |
Human |
OR2B2 |
RF |
|
|
2021 |
33654092 |
| 652 |
Alzheimer's Disease |
Human |
OR52E6 |
PF |
|
APOE-?2 |
2021 |
33576571 |
| 671 |
Alzheimer's Disease |
Human |
OR52E6 |
PF |
|
APOE-?2 |
2021 |
33576571 |
| 640 |
Alzheimer's Disease |
Human |
OR52E6 |
PF |
|
APOE-?2 |
2021 |
33576571 |
| 649 |
Alzheimer's Disease |
Human |
OR52E6 |
PF |
|
APOE-?2 |
2021 |
33576571 |
| 657 |
Alzheimer's Disease |
Human |
OR52E6 |
PF |
|
APOE-?2 |
2021 |
33576571 |
| 3301 |
Alzheimer's Disease |
Human |
OX2R |
RF |
|
A allele may be a susceptible factor for AD |
2019 |
30955315 |
| 3300 |
Alzheimer's Disease |
Human |
OX2R |
RF |
|
A allele may be a susceptible factor for AD |
2019 |
30955315 |
| 3126 |
Alzheimer's Disease |
Human |
oxidized LDL receptor 1(OLR1) |
RF |
|
|
2011 |
21709374 |
| 3137 |
Alzheimer's Disease |
Human |
oxidized LDL receptor 1(OLR1) |
RF |
|
|
2011 |
21709374 |
| 2953 |
Parkinson disease |
Human |
P2RY12 |
RF |
|
|
2020 |
33021140 |
| 3302 |
Parkinson disease |
Human |
P2X7 |
RF |
|
|
2013 |
23648388 |
| 3303 |
Amyotrophic Lateral Sclerosis |
Human |
P4HB/PDIA1 |
RF |
|
|
2015 |
25913742 |
| 3718 |
Alzheimer's Disease |
Human |
paraoxonase 1 (PON1) |
RF |
|
can be ameliorated by B-vitamins in individuals with MCI |
2021 |
33935094 |
| 2396 |
Parkinson disease |
Human |
PARK16 |
RF |
|
|
2011 |
21419001 |
| 3851 |
Parkinson disease |
Human |
PARK16 |
RF |
|
|
2021 |
34373950 |
| 728 |
Parkinson disease |
Human |
PARK16 |
PF |
|
|
2016 |
27174169 |
| 3304 |
Parkinson disease |
Human |
PARK16 |
RF |
|
|
2016 |
27174169 |
| 3306 |
Parkinson disease |
Human |
PARK2 |
RF |
|
|
2014 |
24729340 |
| 3305 |
Parkinson disease |
Human |
PARK2 |
RF |
|
|
2002 |
12056932 |
| 3307 |
Parkinson disease |
Human |
PARK2 |
RF |
|
|
2014 |
24729340 |
| 2386 |
Parkinson disease |
Human |
PARKIN |
RF |
|
|
1999 |
10511432 |
| 3308 |
Parkinson disease |
Human |
PARKIN |
RF |
|
|
2009 |
19636047 |
| 2387 |
Parkinson disease |
Human |
PARKIN |
RF |
|
|
1999 |
10511432 |
| 1855 |
Tourette Syndrome |
Human |
PCNT |
RF |
|
|
2020 |
32099372 |
| 1852 |
Tourette Syndrome |
Human |
PCNT |
RF |
|
|
2020 |
32099372 |
| 1853 |
Tourette Syndrome |
Human |
PCNT |
RF |
|
|
2020 |
32099372 |
| 3309 |
Parkinson disease |
Human |
PD in first-degree relatives |
RF |
|
|
2000 |
11060508 |
| 3812 |
Lewy Body Disease |
Human |
PD-PRS |
RF |
Diagnosis |
|
2021 |
34308904 |
| 2434 |
Amyotrophic Lateral Sclerosis |
Human |
PEAK1 |
RF |
|
|
2013 |
27455347 |
| 572 |
Alzheimer's Disease |
Human |
PELO |
PF |
|
APOE-?2 |
2021 |
33576571 |
| 638 |
Alzheimer's Disease |
Human |
PELO |
PF |
|
APOE-?3 |
2021 |
33576571 |
| 2103 |
Alzheimer's Disease |
Human |
PEMT |
RF |
|
|
2012 |
21881829 |
| 2545 |
Amyotrophic Lateral Sclerosis |
Human |
PFN1 |
RF |
|
|
2014 |
24309268 |
| 2760 |
Alzheimer's Disease |
Human |
PGP |
RF |
|
APOE-?2 |
2021 |
33576571 |
| 2352 |
Alzheimer's Disease |
Human |
PICALM |
RF |
|
PENN cohort |
2018 |
30128317 |
| 2508 |
Alzheimer's Disease |
Human |
PICALM |
RF |
|
PENN cohort |
2018 |
30128317 |
| 3818 |
major depressive disorder (MDD),AD,NDD |
Human |
PICALM mRNA expression |
RF |
|
|
2021 |
33386803 |
| 3824 |
Parkinson disease |
Human |
PICALM mRNA expression |
RF |
Diagnosis |
|
2021 |
33386803 |
| 1869 |
Parkinson disease |
Human |
PINK1 |
RF |
|
|
2017 |
27807026 |
| 3310 |
Parkinson disease |
Human |
PINK1 |
RF |
|
|
2006 |
16969854 |
| 3311 |
Alzheimer's Disease |
Human |
PLA2G3 |
RF |
|
|
2010 |
20930276 |
| 3312 |
Parkinson disease |
Human |
PLA2G6 |
RF |
|
|
2012 |
22213678 |
| 3313 |
Alzheimer's Disease |
Human |
PLEKHG5 |
RF |
|
|
2017 |
29177109 |
| 752 |
Parkinson disease |
Human |
PLEKHN1 |
PF |
Diagnosis |
|
2021 |
33510632 |
| 832 |
Alzheimer's Disease |
Human |
PM20D1 |
PF |
|
in a particular genetic background |
2018 |
29736028 |
| 3314 |
Hereditary Motor and Sensory Neuropathy |
Human |
PMP22 |
RF |
|
17p11.2 duplication |
1997 |
9183252 |
| 3315 |
Hereditary Motor and Sensory Neuropathy |
Human |
PMP22 |
RF |
|
17p11.2 duplication |
1994 |
8179301 |
| 3995 |
Charcot-Marie-Tooth (CMT) disease |
Human |
PMP22 |
RF |
Diagnosis |
|
2023 |
36581210 |
| 695 |
Alzheimer's Disease |
Human |
POMT1 |
PF |
|
APOE-?2 |
2021 |
33576571 |
| 2086 |
Amyotrophic Lateral Sclerosis |
Human |
PON1 Q192R(major allele is Q) |
RF |
|
Additive |
2006 |
16822965 |
| 2106 |
Amyotrophic Lateral Sclerosis |
Human |
PON1 Q192R(major allele is Q) |
RF |
|
Dominant (RR and QR vs QQ) |
2006 |
16822965 |
| 2390 |
Amyotrophic Lateral Sclerosis |
Human |
PON1 Q192R(major allele is Q) |
RF |
|
Recessive (RR vs other) |
2006 |
16822965 |
| 2132 |
Amyotrophic Lateral Sclerosis |
Human |
PON2 C311S (major allele is S) |
RF |
|
Dominant (CC and CS vs SS) |
2006 |
16822965 |
| 2046 |
Amyotrophic Lateral Sclerosis |
Human |
PON2 C311S (major allele is S) |
RF |
|
Additive |
2006 |
16822965 |
| 2836 |
Parkinson disease |
Human |
positive family history of PD |
RF |
|
|
1998 |
9778597 |
| 2631 |
Alzheimer's Disease |
Human |
PRAME |
RF |
|
APOE-?2 |
2021 |
33576571 |
| 1699 |
Alzheimer's Disease |
Human |
presence of one or more APOE ε4 alleles |
RF |
|
in females |
2015 |
26343475 |
| 746 |
Alzheimer's Disease |
Human |
PRKAG3 |
PF |
|
APOE-?3 |
2021 |
33576571 |
| 2588 |
Alzheimer's Disease |
Human |
PRKAG3 |
RF |
|
APOE-?2 |
2021 |
33576571 |
| 3846 |
Parkinson disease |
Human |
PRKN |
RF |
|
|
2021 |
34434164 |
| 1784 |
Parkinson disease |
Human |
PRKN |
RF |
Diagnosis |
|
2021 |
33448283 |
| 3871 |
Parkinson disease |
Human |
PRKN |
RF |
Diagnosis |
|
2021 |
33742109 |
| 1964 |
Creutzfeldt-Jakob disease |
Human |
PRNP |
RF |
|
|
2020 |
32949544 |
| 2166 |
Creutzfeldt-Jakob disease |
Human |
PRNP |
RF |
|
BACE1?C-allele carriers |
2012 |
22952813 |
| 3793 |
Creutzfeldt-Jakob disease |
Human |
PRNP |
RF |
Diagnosis |
|
2021 |
33917419 |
| 3316 |
Creutzfeldt-Jakob disease |
Human |
PRNP |
RF |
|
Codon 129: Val homozygosity |
1996 |
8707291 |
| 3878 |
Prion disease |
moose |
PRNP |
RF |
Diagnosis |
|
2021 |
34346562 |
| 2918 |
Creutzfeldt-Jakob disease |
Human |
PRNP |
RF |
|
|
2009 |
19081515 |
| 2884 |
Fatal familial insomnia (FFI) |
Human |
PRNP |
RF |
Diagnosis |
|
2021 |
34667102 |
| 3004 |
Creutzfeldt-Jakob disease |
Human |
PRNP |
RF |
Diagnosis |
|
2021 |
34831353 |
| 3794 |
Creutzfeldt-Jakob disease |
Human |
PRNP |
RF |
Diagnosis |
|
2021 |
33917419 |
| 2882 |
Creutzfeldt-Jakob disease |
Human |
PRNP |
RF |
|
|
2009 |
19081515 |
| 2974 |
Creutzfeldt-Jakob disease |
Human |
PRNP |
RF |
|
APOE?ε4 carriers |
2011 |
21799773 |
| 2484 |
Creutzfeldt-Jakob disease |
Human |
PRNP |
RF |
|
|
2012 |
22210626 |
| 2405 |
Creutzfeldt-Jakob disease |
Human |
PRNP |
RF |
|
BACE1?C-allele carriers |
2012 |
22952813 |
| 3022 |
Alzheimer's Disease |
Human |
PRPH |
RF |
|
APOE-?2 |
2021 |
33576571 |
| 2161 |
Alzheimer's Disease |
Human |
PRSS48 |
RF |
|
APOE-?2 |
2021 |
33576571 |
| 2415 |
Alzheimer's Disease |
Human |
PS-1 |
RF |
|
APOE ε4 |
1999 |
10581373 |
| 3318 |
Alzheimer's Disease |
Human |
PS-1 |
RF |
|
|
1997 |
9298817 |
| 3317 |
Alzheimer's Disease |
Human |
PS-1 |
RF |
|
|
1996 |
8930979 |
| 3105 |
Alzheimer's Disease |
Human |
PS-2 |
RF |
|
APOE ε4 |
1999 |
10581373 |
| 3319 |
Alzheimer's Disease |
Human |
PSEN1 |
RF |
|
|
2014 |
25104557 |
| 3320 |
Dementia with Lewy bodies |
Human |
PSEN1 |
RF |
|
|
2016 |
27312774 |
| 3321 |
Alzheimer's Disease |
Human |
PSEN2 |
RF |
|
|
2014 |
25104557 |
| 3928 |
Alzheimer's Disease |
Human |
PSEN2 |
RF |
Diagnosis |
|
2022 |
36362122 |
| 3322 |
Alzheimer's Disease |
Human |
PSEN2 |
RF |
|
|
2014 |
24927704 |
| 2233 |
Alzheimer's Disease |
Human |
PSMB7 |
RF |
|
APOE-?2 |
2021 |
33576571 |
| 3101 |
Alzheimer's Disease |
Human |
PTBP1 |
RF |
|
APOE-?3 |
2021 |
33576571 |
| 642 |
Alzheimer's Disease |
Human |
PTCH1 |
PF |
|
APOE-?2 |
2021 |
33576571 |
| 763 |
Alzheimer's Disease |
Human |
PTK2B |
PF |
|
National Alzheimer’s Coordinating Center (NACC) cohort |
2018 |
30128317 |
| 3791 |
Amyotrophic lateral sclerosis,Parkinson disease |
Human |
PTPRT |
RF |
Diagnosis |
|
2021 |
34707478 |
| 3324 |
Alzheimer's Disease |
Human |
PVRL2 |
RF |
|
eQTL(expression quantitative trait loci) analysis for the five SNPs closely related to AD |
2018 |
30319691 |
| 3323 |
Alzheimer's Disease |
Human |
PVRL2 |
RF |
|
eQTL(expression quantitative trait loci) analysis for the five SNPs closely related to AD |
2018 |
30319691 |
| 2261 |
Alzheimer's Disease |
Human |
PVRL2 |
RF |
|
using logistic regression、Dataset:LOADFS(Late Onset Alzheimer's Disease Family Study ) |
2018 |
29107063 |
| 2064 |
Alzheimer's Disease |
Human |
PVRL2 |
RF |
|
using logistic regression、Dataset:CHS( Cardiovascular Health Study) |
2018 |
29107063 |
| 3325 |
Alzheimer's Disease |
Human |
PVRL2 |
RF |
|
eQTL(expression quantitative trait loci) analysis for the five SNPs closely related to AD |
2018 |
30319691 |
| 2114 |
Alzheimer's Disease |
Human |
PVRL2 |
RF |
|
using logistic regression、Dataset:HRS(Health and Retirement Study) |
2018 |
29107063 |
| 1573 |
Alzheimer's Disease |
Human |
PVRL2 |
RF |
|
using Cox regression、Dataset:CHS(Cardiovascular Health Study) |
2018 |
29107063 |
| 3091 |
Alzheimer's Disease |
Human |
QPCTL |
RF |
|
APOE-?2 |
2021 |
33576571 |
| 4015 |
Huntington's disease (HD) |
Human |
RCAN1 |
RF |
Treatment |
RCAN1 knockdown rescued patient-derived medium spiny neurons (MSNs) |
2023 |
38066314 |
| 3326 |
Alzheimer's Disease |
Human |
RCAN1 |
RF |
|
|
2015 |
26497675 |
| 3327 |
Alzheimer's Disease |
Human |
RCAN1 |
RF |
|
|
2015 |
26497675 |
| 2019 |
Alzheimer's Disease |
Human |
reduced folate carrier gene (RFC1) |
RF |
|
especially for female individuals |
2009 |
18258338 |
| 2058 |
Alzheimer's Disease |
Human |
reduced folate carrier gene (RFC1) |
RF |
|
especially for female individuals |
2009 |
18258338 |
| 700 |
Frontotemporal Lobar Degeneration |
Human |
RERG |
PF |
|
Discovery stage |
2019 |
30739198 |
| 2378 |
Alzheimer's Disease |
Human |
RIPK2 |
RF |
|
APOE-?2 |
2021 |
33576571 |
| 3845 |
Parkinson disease |
Human |
RP11-305E6 |
RF |
|
|
2021 |
34394198 |
| 833 |
Parkinson disease |
Human |
Saitohin |
PF |
|
|
2015 |
25168738 |
| 3329 |
Parkinson disease |
Human |
Saitohin |
RF |
|
|
2015 |
25168738 |
| 3330 |
Multiple System Atrophy |
Human |
SCA1 |
RF |
|
|
2018 |
29715545 |
| 3331 |
Multiple System Atrophy |
Human |
SCA3 |
RF |
|
|
2007 |
17133518 |
| 3003 |
Alzheimer's Disease |
Human |
SCAF11 |
RF |
|
APOE-?3 |
2021 |
33576571 |
| 558 |
Alzheimer's Disease |
Human |
SCAF11 |
PF |
|
APOE-?2 |
2021 |
33576571 |
| 1833 |
Lewy Body Disease |
Human |
SCARB2 |
RF |
Diagnosis |
|
2021 |
34308904 |
| 553 |
Parkinson disease |
Human |
SEMA5A |
PF |
|
|
2008 |
18950607 |
| 2308 |
Parkinson disease |
Human |
SEMA5A |
RF |
|
|
2008 |
18950607 |
| 552 |
Parkinson disease |
Human |
SEMA5A |
PF |
|
|
2008 |
18950607 |
| 2307 |
Parkinson disease |
Human |
SEMA5A |
RF |
|
|
2008 |
18950607 |
| 798 |
Parkinson disease |
Human |
SEMA5A |
PF |
|
|
2014 |
24706317 |
| 3019 |
Alzheimer's Disease |
Human |
SEMA6A |
RF |
|
APOE-?2 |
2021 |
33576571 |
| 3106 |
Alzheimer's Disease |
Human |
SERPINE1 |
RF |
|
women were at an increased risk over their male genotype counterparts |
2017 |
28466654 |
| 2965 |
Alzheimer's Disease |
Human |
SERPINE1 |
RF |
|
women were at an increased risk over their male genotype counterparts |
2017 |
28466654 |
| 2925 |
Alzheimer's Disease |
Human |
SERPINE2 |
RF |
|
APOE-?2 |
2021 |
33576571 |
| 2309 |
Alzheimer's Disease |
Human |
SFTPB |
RF |
|
APOE-?2 |
2021 |
33576571 |
| 2763 |
Alzheimer's Disease |
Human |
SH3D19 |
RF |
|
APOE-?3 |
2021 |
33576571 |
| 3052 |
Alzheimer's Disease |
Human |
SHARPIN |
RF |
|
|
2019 |
31216982 |
| 3707 |
Alzheimer's Disease |
Human |
SIGLEC14 |
RF |
|
|
2021 |
34208838 |
| 3332 |
Alzheimer's Disease |
Human |
SIRT2 |
RF |
|
|
2014 |
24139700 |
| 2227 |
Alzheimer's Disease |
Human |
SIRT2 |
RF |
|
APOEε4 noncarriers |
2014 |
24139700 |
| 595 |
Alzheimer's Disease |
Human |
SLC35G6 |
PF |
|
APOE-?2 |
2021 |
33576571 |
| 617 |
Alzheimer's Disease |
Human |
SLC35G6 |
PF |
|
APOE-?2 |
2021 |
33576571 |
| 1982 |
Parkinson disease |
Human |
SLC6A3 |
RF |
|
|
2014 |
24211691 |
| 2051 |
Parkinson disease |
Human |
SLC6A3 |
RF |
|
|
2014 |
24211691 |
| 770 |
Parkinson disease |
Human |
SLC6A3 |
PF |
|
|
2014 |
24211691 |
| 1981 |
Parkinson disease |
Human |
SLC6A3 |
RF |
|
|
2014 |
24211691 |
| 2050 |
Parkinson disease |
Human |
SLC6A3 |
RF |
|
|
2014 |
24211691 |
| 578 |
Alzheimer's Disease |
Human |
SLC6A4/5-HTT |
PF |
|
S allele; AD with depression |
2018 |
29703883 |
| 709 |
Progressive Supranuclear Palsy |
Human |
SLCO1A2 |
PF |
|
Meta-analysis |
2018 |
29986742 |
| 2661 |
Amyotrophic Lateral Sclerosis |
Human |
SMN1 |
RF |
|
three copies |
2006 |
16931506 |
| 2723 |
Amyotrophic Lateral Sclerosis |
Human |
SMN1 |
RF |
|
one or three copies of SMN1 gene were pooled |
2006 |
16931506 |
| 3994 |
Spinal muscular atrophy (SMA) |
Human |
SMN1 |
RF |
Diagnosis |
|
2023 |
37964750 |
| 2796 |
Amyotrophic Lateral Sclerosis |
Human |
SMN1 |
RF |
|
one copy |
2006 |
16931506 |
| 2596 |
Amyotrophic Lateral Sclerosis |
Human |
SMN1 |
RF |
|
abnormal SMN1 copy numbers |
2009 |
19922137 |
| 3333 |
Amyotrophic Lateral Sclerosis |
Human |
SMN2 |
RF |
|
|
2011 |
22187232 |
| 3334 |
Parkinson disease |
Human |
SMPD1 |
RF |
|
|
2015 |
26169695 |
| 2330 |
Alzheimer's Disease |
Human |
SMPD4 |
RF |
|
APOE-?3 |
2021 |
33576571 |
| 621 |
Alzheimer's Disease |
Human |
SMTNL1 |
PF |
|
APOE-?2 |
2021 |
33576571 |
| 733 |
Alzheimer's Disease |
Human |
SMTNL1 |
PF |
|
APOE-?3 |
2021 |
33576571 |
| 3838 |
Parkinson disease |
Human |
SNCA |
RF |
Diagnosis |
|
2021 |
33994928 |
| 742 |
Dementia with Lewy bodies |
Human |
SNCA |
PF |
|
|
2018 |
29263008 |
| 1972 |
Parkinson disease |
Human |
SNCA |
RF |
|
|
2008 |
18404644 |
| 3129 |
Parkinson disease |
Human |
SNCA |
RF |
Diagnosis |
|
2021 |
33705925 |
| 3843 |
Parkinson disease |
Human |
SNCA |
RF |
|
|
2021 |
34394198 |
| 2047 |
Lewy Body Disease |
Human |
SNCA |
RF |
Diagnosis |
|
2021 |
34308904 |
| 1971 |
Parkinson disease |
Human |
SNCA |
RF |
|
|
2008 |
18404644 |
| 708 |
Parkinson disease |
Human |
SNCA |
PF |
Diagnosis |
|
2021 |
34946922 |
| 3808 |
Lewy Body Disease |
Human |
SNCA |
RF |
Diagnosis |
|
2021 |
33994928 |
| 3142 |
Parkinson disease |
Human |
SNCA |
RF |
|
|
2016 |
27699750 |
| 3801 |
Lewy Body Disease |
Human |
SNCA |
RF |
|
|
2021 |
34308904 |
| 2357 |
Parkinson disease |
Human |
SNCA |
RF |
|
|
2012 |
22349157 |
| 2419 |
Alzheimer's Disease |
Human |
SNX27 |
RF |
|
APOE-?2 |
2021 |
33576571 |
| 3335 |
Amyotrophic Lateral Sclerosis |
Human |
SOD1 |
RF |
|
Expression of N19S-SOD1, an SOD1 Mutant |
2005 |
16035108 |
| 3336 |
Amyotrophic Lateral Sclerosis |
Human |
SOD1 |
RF |
|
|
2014 |
24591609 |
| 627 |
Alzheimer's Disease |
Human |
SOD1 gene |
PF |
|
After Bonferroni correction;additive model |
2014 |
25440013 |
| 590 |
Alzheimer's Disease |
Human |
SOD1 gene |
PF |
|
Logistic regression analysis controlled for age, genderand APOE carrier status;recessive model |
2014 |
25440013 |
| 589 |
Alzheimer's Disease |
Human |
SOD1 gene |
PF |
|
Logistic regression analysis controlled for age, genderand APOE carrier status;additive model |
2014 |
25440013 |
| 637 |
Alzheimer's Disease |
Human |
SOD1 gene |
PF |
|
After Bonferroni correction;recessive model |
2014 |
25440013 |
| 3760 |
Alzheimer's Disease |
Human |
SORCS3 |
RF |
|
|
2021 |
32966694 |
| 3338 |
Alzheimer's Disease |
Human |
SORL1 |
RF |
|
|
2009 |
19368828 |
| 3916 |
Alzheimer's Disease |
Human |
SORL1 |
RF |
Diagnosis |
|
2022 |
35457051 |
| 3706 |
Alzheimer's Disease |
Human |
SORL1 |
RF |
|
|
2021 |
34214049 |
| 2059 |
Alzheimer's Disease |
Human |
SORL1 |
RF |
|
adjusted for age and gender |
2015 |
25881907 |
| 3908 |
Alzheimer's Disease |
Human |
SORL1 |
RF |
Diagnosis |
|
2022 |
35456392 |
| 3108 |
Alzheimer's Disease |
Human |
SORL1 |
RF |
|
when restricting the analysis to the 205 cases with a positive family history |
2016 |
26303663 |
| 2404 |
Alzheimer's Disease |
Human |
SORL1 |
RF |
|
|
2014 |
24486888 |
| 2053 |
Alzheimer's Disease |
Human |
SORL1 |
RF |
|
adjusted foe age, gender, APOE 4 |
2015 |
25881907 |
| 3010 |
Alzheimer's Disease |
Human |
SORL1 |
RF |
|
|
2016 |
26303663 |
| 3337 |
Alzheimer's Disease |
Human |
SORL1 |
RF |
|
with the A allele |
2015 |
25450149 |
| 3915 |
Alzheimer's Disease |
Human |
SORL1 |
RF |
Diagnosis |
|
2022 |
35457051 |
| 834 |
Alzheimer's Disease |
Human |
SORL1 |
PF |
|
|
2008 |
18407551 |
| 823 |
Alzheimer's Disease |
Human |
SORL1 |
PF |
|
|
2018 |
30009200 |
| 674 |
Alzheimer's Disease |
Human |
SORT1 |
PF |
|
|
2016 |
27392867 |
| 3339 |
Amyotrophic Lateral Sclerosis |
Human |
SPG4 |
RF |
|
|
2005 |
16009903 |
| 3672 |
Amyotrophic Lateral Sclerosis |
Human |
SPG7 mutations |
RF |
|
|
2020 |
32447552 |
| 3340 |
Amyotrophic Lateral Sclerosis |
Human |
SQSTM1 |
RF |
|
|
2012 |
22972638 |
| 3341 |
Alzheimer's Disease |
Human |
SREBF2 |
RF |
|
significant dual associations with LOAD pathological biomarkers and gene expression levels |
2018 |
29503034 |
| 2529 |
Alzheimer's Disease |
Human |
STARD6 |
RF |
|
in combination with the APOE ε4 allele |
2019 |
30666118 |
| 559 |
Alzheimer's Disease |
Human |
STEAP1B |
PF |
|
APOE-?2 |
2021 |
33576571 |
| 1987 |
Alzheimer's Disease |
Human |
STH |
RF |
|
especially in caucasian population, late‐onset AD subjects and studies with high quality |
2017 |
28211174 |
| 2218 |
Parkinson disease |
Human |
STK39 |
RF |
|
|
2015 |
26469904 |
| 2914 |
Amyotrophic Lateral Sclerosis |
Human |
STX12 |
RF |
|
|
2013 |
27455347 |
| 775 |
Progressive Supranuclear Palsy |
Human |
STX6 |
PF |
|
Meta-analysis |
2018 |
29986742 |
| 1917 |
Creutzfeldt-Jakob disease |
Human |
STX6(Syntaxin-6) |
RF |
|
|
2020 |
32949544 |
| 3343 |
Amyotrophic Lateral Sclerosis |
Human |
SUN3, HUS1 |
RF |
|
|
2014 |
25023141 |
| 3869 |
Parkinson disease |
Human |
SV2C |
RF |
Diagnosis |
|
2021 |
33760272 |
| 3344 |
Alzheimer's Disease |
Human |
SYMPK |
RF |
|
eQTL(expression quantitative trait loci) analysis for the five SNPs closely related to AD |
2018 |
30319691 |
| 2147 |
Alzheimer's Disease |
Human |
SYTL2 |
RF |
|
APOE-?3 |
2021 |
33576571 |
| 639 |
Alzheimer's Disease |
Human |
SYTL2 |
PF |
|
APOE-?2 |
2021 |
33576571 |
| 2376 |
Alzheimer's Disease |
Human |
SYTL2 |
RF |
|
APOE-?3 |
2021 |
33576571 |
| 596 |
Alzheimer's Disease |
Human |
SYTL2 |
PF |
|
APOE-?2 |
2021 |
33576571 |
| 650 |
Alzheimer's Disease |
Human |
SYTL2 |
PF |
|
APOE-?2 |
2021 |
33576571 |
| 2858 |
Alzheimer's Disease |
Human |
SYTL2 |
RF |
|
APOE-?2 |
2021 |
33576571 |
| 667 |
Alzheimer's Disease |
Human |
SYTL2 |
PF |
|
APOE-?2 |
2021 |
33576571 |
| 3346 |
Frontotemporal Lobar Degeneration |
Human |
TARDBP |
RF |
|
|
2008 |
18505686 |
| 3345 |
Amyotrophic Lateral Sclerosis |
Human |
TARDBP |
RF |
|
|
2014 |
25023141 |
| 3778 |
Amyotrophic Lateral Sclerosis |
Human |
TATA-box binding protein gene (TBP) |
RF |
Diagnosis |
|
2021 |
33377399 |
| 2686 |
Frontotemporal Lobar Degeneration |
Human |
tau |
RF |
|
tau Genotype:H1H1;absence of APOE E2 allele |
2002 |
12056929 |
| 3927 |
Alzheimer's Disease |
Human |
tau |
RF |
Diagnosis |
|
2022 |
35348036 |
| 2846 |
Frontotemporal Lobar Degeneration |
Human |
tau |
RF |
|
tau Genotype:H1H2+H2H2;presence of APOE E2 allele |
2002 |
12056929 |
| 3349 |
Progressive Supranuclear Palsy |
Human |
tau A0/A0 genotype |
RF |
|
|
1998 |
9708963 |
| 3348 |
Progressive Supranuclear Palsy |
Human |
tau A0/A0 genotype |
RF |
|
|
1998 |
9708963 |
| 3118 |
Frontotemporal Lobar Degeneration |
Human |
tau,APOE |
RF |
|
tau A3,APOE ε4 |
2001 |
11303757 |
| 2971 |
Alzheimer's Disease |
Human |
TBC1D4 |
RF |
|
APOE-?2 |
2021 |
33576571 |
| 2367 |
Alzheimer's Disease |
Human |
TCF7 |
RF |
|
APOE-?2 |
2021 |
33576571 |
| 3828 |
Parkinson disease |
Human |
TENM4 |
RF |
Diagnosis |
|
2021 |
33185019 |
| 2535 |
Alzheimer's Disease |
Human |
TESK2 |
RF |
|
APOE-?2 |
2021 |
33576571 |
| 2310 |
Parkinson disease |
Human |
TFAM |
RF |
|
|
2010 |
19925850 |
| 2381 |
Alzheimer's Disease |
Human |
TFAM |
RF |
|
|
2008 |
18430995 |
| 2311 |
Alzheimer's Disease |
Human |
TGF-β1 |
RF |
|
without the ApoE ε4 allele;G |
2016 |
26327336 |
| 2472 |
Alzheimer's Disease |
Human |
TGF-β1 |
RF |
|
Genotype AC |
2016 |
26327336 |
| 2160 |
Alzheimer's Disease |
Human |
TGF-β1 |
RF |
|
without the ApoE ε4allele;C |
2016 |
26327336 |
| 2270 |
Alzheimer's Disease |
Human |
TGF-β1 |
RF |
|
without the ApoE ε4 allele;AC |
2016 |
26327336 |
| 2238 |
Alzheimer's Disease |
Human |
TGF-β1 |
RF |
|
allele C |
2016 |
26327336 |
| 2081 |
Alzheimer's Disease |
Human |
TGF-β1 |
RF |
|
allele G |
2016 |
26327336 |
| 2229 |
Alzheimer's Disease |
Human |
TGF-β1 |
RF |
|
Genotype TG |
2016 |
26327336 |
| 2713 |
Alzheimer's Disease |
Human |
TGF-β1 |
RF |
|
AC+ CC vs AA |
2016 |
26327336 |
| 2363 |
Alzheimer's Disease |
Human |
TGF-β1 |
RF |
|
without the ApoE ε4 allele;TG |
2016 |
26327336 |
| 3143 |
Parkinson disease |
Human |
TH |
RF |
|
|
2010 |
20809526 |
| 3350 |
Alzheimer's Disease |
Human |
THBS2 |
RF |
|
|
2017 |
29177109 |
| 3351 |
Dementia with Lewy bodies |
Human |
The apolipoprotein E (APOE) ε4 allele |
RF |
|
|
2011 |
21552550 |
| 2490 |
Alzheimer's Disease |
Human |
THG1L |
RF |
|
APOE-?2 |
2021 |
33576571 |
| 2481 |
Amyotrophic Lateral Sclerosis |
Human |
TIAM1 |
RF |
|
|
2010 |
20801718 |
| 3352 |
Amyotrophic Lateral Sclerosis |
Human |
TIAM1 |
RF |
|
|
2014 |
25023141 |
| 643 |
Alzheimer's Disease |
Human |
TLR2 |
PF |
|
|
2015 |
26738351 |
| 835 |
Alzheimer's Disease |
Human |
TLR4 |
PF |
|
when incorporated into a haplotype with rs10759930, the strongest association was detected |
2012 |
22272615 |
| 3798 |
Frontotemporal Lobar Degeneration |
Human |
TMEM106B |
RF |
Diagnosis |
|
2021 |
33314436 |
| 2479 |
Frontotemporal Lobar Degeneration |
Human |
TMEM106B |
RF |
|
for chromosome 9 SNP association; Denotes the associated SNP’s from the GWAS. |
2011 |
21257233 |
| 662 |
Frontotemporal Lobar Degeneration |
Human |
TMEM106B |
PF |
|
GRN carriers |
2014 |
25085782 |
| 3814 |
Lewy Body Disease |
Human |
TMEM106B |
RF |
Diagnosis |
|
2021 |
34854996 |
| 2553 |
Frontotemporal Lobar Degeneration |
Human |
TMEM106B |
RF |
|
for chromosome 9 SNP association; Denotes the associated SNP’s from the GWAS;Denotes the associated SNP’s from the ALS GWAS |
2011 |
21257233 |
| 2607 |
Frontotemporal Lobar Degeneration |
Human |
TMEM106B |
RF |
|
for chromosome 9 SNP association; Denotes the associated SNP’s from the GWAS. |
2011 |
21257233 |
| 2512 |
Frontotemporal Lobar Degeneration |
Human |
TMEM106B |
RF |
|
for chromosome 9 SNP association |
2011 |
21257233 |
| 2317 |
Frontotemporal Lobar Degeneration |
Human |
TMEM106B |
RF |
|
for chromosome 9 SNP association |
2011 |
21257233 |
| 2235 |
Frontotemporal Lobar Degeneration |
Human |
TMEM106B |
RF |
|
for chromosome 1 SNP association |
2011 |
21257233 |
| 2244 |
Frontotemporal Lobar Degeneration |
Human |
TMEM106B |
RF |
|
for chromosome 9 SNP association |
2011 |
21257233 |
| 2549 |
Frontotemporal Lobar Degeneration |
Human |
TMEM106B |
RF |
|
for chromosome 9 SNP association |
2011 |
21257233 |
| 837 |
Frontotemporal Dementia |
Human |
TMEM106B |
PF |
|
C9ORF72 expansion carriers;Cohort 1 – controls and C9ORF72 repeat expansion carriers (FTD, FTD/MND, and MND, or other diagnosis) |
2014 |
24385136 |
| 3673 |
Frontotemporal Lobar Degeneration |
Human |
TMEM106B |
RF |
|
FTLD with TAR DNA-binding protein (TDP-43) inclusions |
2010 |
20154673 |
| 668 |
Frontotemporal Lobar Degeneration |
Human |
TMEM106B |
PF |
|
for SNPs on chromosomes 1, 8, 10 and 11 genotyped |
2011 |
21257233 |
| 1849 |
Frontotemporal Lobar Degeneration |
Human |
TMEM106B |
RF |
|
for chromosome 1 SNP association |
2011 |
21257233 |
| 836 |
Frontotemporal Dementia |
Human |
TMEM106B |
PF |
|
C9ORF72 expansion carriers;Cohort 1 – controls and C9ORF72 repeat expansion carriers (FTD, FTD/MND, and MND, or other diagnosis) |
2014 |
24385136 |
| 2318 |
Frontotemporal Lobar Degeneration |
Human |
TMEM106B |
RF |
|
for chromosome 9 SNP association; Denotes the associated SNP’s from the GWAS. |
2011 |
21257233 |
| 2489 |
Frontotemporal Lobar Degeneration |
Human |
TMEM106B |
RF |
|
for chromosome 9 SNP association |
2011 |
21257233 |
| 3353 |
Alzheimer's Disease |
Human |
TMEM106B |
RF |
|
APOE interact |
2014 |
24166182 |
| 3777 |
Amyotrophic Lateral Sclerosis |
Human |
TMEM106B |
RF |
Diagnosis |
|
2021 |
33314436 |
| 2942 |
Frontotemporal Lobar Degeneration |
Human |
TMEM106B |
RF |
|
for chromosome 9 SNP association |
2011 |
21257233 |
| 1830 |
Lewy Body Disease |
Human |
TMEM175 |
RF |
Diagnosis |
|
2021 |
34308904 |
| 3354 |
Alzheimer's Disease |
Human |
TMP21 |
RF |
|
|
2018 |
28233271 |
| 3733 |
Alzheimer's Disease |
Human |
TNFRSF13C |
RF |
|
|
2021 |
33687622 |
| 3355 |
Alzheimer's Disease |
Human |
TNFRSF1A, CDH1, CASP7, LRP1B and TG |
RF |
|
|
2015 |
26621834 |
| 1968 |
Multiple System Atrophy |
Human |
TNF-α |
RF |
|
genotype |
2018 |
29251119 |
| 2358 |
Multiple System Atrophy |
Human |
TNF-α |
RF |
|
allele |
2018 |
29251119 |
| 1329 |
Alzheimer's Disease |
Human |
TNF-α |
RF |
|
in the APOE epsilon4 non-carriers |
2008 |
18396294 |
| 1334 |
Alzheimer's Disease |
Human |
TNF-α |
RF |
|
in the APOE epsilon4 non-carriers |
2008 |
18396294 |
| 2770 |
Alzheimer's Disease |
Human |
TNF-α -308 |
RF |
|
AA vs. GG |
2015 |
25647294 |
| 2452 |
Alzheimer's Disease |
Human |
TNF-α -308 |
RF |
|
AA vs. AG |
2015 |
25647294 |
| 2766 |
Alzheimer's Disease |
Human |
TNF-α -308 |
RF |
|
AA vs. AG + GG (recessive) |
2015 |
25647294 |
| 2104 |
Alzheimer's Disease |
Human |
TNF-α -308 |
RF |
|
AA + AG vs. GG (dominant) |
2015 |
25647294 |
| 2295 |
Alzheimer's Disease |
Human |
TNF-α -308 |
RF |
|
A vs. G allele |
2015 |
25647294 |
| 3358 |
Alzheimer's Disease |
Human |
TOMM40 |
RF |
|
|
2018 |
30443289 |
| 2885 |
Alzheimer's Disease |
Human |
TOMM40 |
RF |
|
APOE ε4+ |
2021 |
32725468 |
| 690 |
Alzheimer's Disease |
Human |
TOMM40 |
PF |
|
the association between the Asian and Caucasian groups was significantly different |
2016 |
26795201 |
| 1589 |
Alzheimer's Disease |
Human |
TOMM40 |
RF |
|
using Cox regression、Dataset:HRS(Health and Retirement Study) |
2018 |
29107063 |
| 2896 |
Alzheimer's Disease |
Human |
TOMM40 |
RF |
|
APOE ε4+ |
2021 |
32725468 |
| 1673 |
Alzheimer's Disease |
Human |
TOMM40 |
RF |
|
using Cox regression、Dataset:CHS(Cardiovascular Health Study) |
2018 |
29107063 |
| 2184 |
Alzheimer's Disease |
Human |
TOMM40 |
RF |
|
using logistic regression、Dataset:HRS(Health and Retirement Study) |
2018 |
29107063 |
| 2565 |
Alzheimer's Disease |
Human |
TOMM40 |
RF |
|
using logistic regression、Dataset:FHS(Framingham Heart Study) |
2018 |
29107063 |
| 1621 |
Alzheimer's Disease |
Human |
TOMM40 |
RF |
|
using Cox regression、Dataset:FHS(Framingham Heart Study) |
2018 |
29107063 |
| 2115 |
Alzheimer's Disease |
Human |
TOMM40 |
RF |
|
using logistic regression、Dataset:HRS(Health and Retirement Study) |
2018 |
29107063 |
| 3696 |
Alzheimer's Disease |
Human |
TOMM40 |
RF |
|
|
2021 |
34336000 |
| 3357 |
Alzheimer's Disease |
Human |
TOMM40 |
RF |
|
|
2018 |
29797398 |
| 1588 |
Alzheimer's Disease |
Human |
TOMM40 |
RF |
|
using Cox regression、Dataset:HRS(Health and Retirement Study) |
2018 |
29107063 |
| 2935 |
Alzheimer's Disease |
Human |
TOMM40 |
RF |
|
APOE ε4+ |
2021 |
32725468 |
| 2445 |
Alzheimer's Disease |
Human |
TOMM40 |
RF |
|
APOE ε4+ |
2021 |
32725468 |
| 2564 |
Alzheimer's Disease |
Human |
TOMM40 |
RF |
|
using logistic regression、Dataset:CHS( Cardiovascular Health Study) |
2018 |
29107063 |
| 3839 |
Parkinson disease |
Human |
TOMM40 |
RF |
|
carriage of shorter '523' alleles |
2021 |
34234128 |
| 2440 |
Alzheimer's Disease |
Human |
TOMM40 |
RF |
|
APOE ε4+ |
2021 |
32725468 |
| 2862 |
Alzheimer's Disease |
Human |
TOMM40 |
RF |
|
using logistic regression、Dataset:LOADFS(Late Onset Alzheimer's Disease Family Study ) |
2018 |
29107063 |
| 3356 |
Alzheimer's Disease |
Human |
TOMM40 |
RF |
|
|
2018 |
29797398 |
| 2964 |
Alzheimer's Disease |
Human |
TOMM40 |
RF |
|
APOE ε4+ |
2021 |
32725468 |
| 894 |
Parkinson disease |
Human |
TOMM40 |
PF |
|
carriage of longer '523' alleles |
2021 |
34234128 |
| 2116 |
Alzheimer's Disease |
Human |
TOMM40 |
RF |
|
using logistic regression、Dataset:HRS(Health and Retirement Study) |
2018 |
29107063 |
| 2735 |
Alzheimer's Disease |
Human |
TOMM40 |
RF |
|
the association between the Asian and Caucasian groups was significantly different |
2016 |
26795201 |
| 2585 |
Alzheimer's Disease |
Human |
TOX |
RF |
|
APOE-?2 |
2021 |
33576571 |
| 1488 |
Frontotemporal Dementia |
Human |
TP53 |
RF |
Diagnosis |
|
2021 |
32972771 |
| 594 |
Alzheimer's Disease |
Human |
TRAF3IP2 |
PF |
|
APOE-?2 |
2021 |
33576571 |
| 739 |
Alzheimer's Disease |
Human |
TRAF3IP2 |
PF |
|
APOE-?3 |
2021 |
33576571 |
| 3011 |
Frontotemporal Dementia |
Human |
TREM2 |
RF |
|
|
2013 |
23800361 |
| 2559 |
Frontotemporal Lobar Degeneration |
Human |
TREM2 |
RF |
|
CT vs. CC |
2018 |
29322490 |
| 2693 |
Parkinson disease |
Human |
TREM2 |
RF |
|
|
2013 |
23800361 |
| 3363 |
Frontotemporal Lobar Degeneration |
Human |
TREM2 |
RF |
|
Compound heterozygosity |
2018 |
29557178 |
| 2427 |
Alzheimer's Disease |
Human |
TREM2 |
RF |
|
the T allele of the rs75932628 variant of TREM2 |
2015 |
25260849 |
| 3076 |
Alzheimer's Disease |
Human |
TREM2 |
RF |
|
APOE-?2 |
2021 |
33576571 |
| 2704 |
Alzheimer's Disease |
Human |
TREM2 |
RF |
|
|
2015 |
25936935 |
| 2849 |
Alzheimer's Disease |
Human |
TREM2 |
RF |
|
|
2013 |
23855982 |
| 2678 |
Frontotemporal Lobar Degeneration |
Human |
TREM2 |
RF |
|
T vs. G |
2018 |
29322490 |
| 3360 |
Alzheimer's Disease |
Human |
TREM2 |
RF |
|
|
2018 |
29794134 |
| 2383 |
Alzheimer's Disease |
Human |
TREM2 |
RF |
|
|
2014 |
24439484 |
| 3365 |
Frontotemporal Lobar Degeneration |
Human |
TREM2 |
RF |
|
Compound heterozygosity |
2018 |
29557178 |
| 2933 |
Alzheimer's Disease |
Human |
TREM2 |
RF |
|
|
2014 |
24041969 |
| 2680 |
Frontotemporal Lobar Degeneration |
Human |
TREM2 |
RF |
|
GT vs. GG |
2018 |
29322490 |
| 2907 |
Alzheimer's Disease |
Human |
TREM2 |
RF |
|
APOE-?3 |
2021 |
33576571 |
| 2558 |
Frontotemporal Lobar Degeneration |
Human |
TREM2 |
RF |
|
CT+TT vs. CC |
2018 |
29322490 |
| 3362 |
Frontotemporal Lobar Degeneration |
Human |
TREM2 |
RF |
|
A large consanguineous Colombian family segregating autosomal recessive FTLD |
2013 |
23582655 |
| 2609 |
Amyotrophic Lateral Sclerosis |
Human |
TREM2 |
RF |
|
|
2014 |
24535663 |
| 2703 |
Alzheimer's Disease |
Human |
TREM2 |
RF |
|
|
2015 |
26037549 |
| 2928 |
Alzheimer's Disease |
Human |
TREM2 |
RF |
|
|
2013 |
23380991 |
| 3367 |
Frontotemporal Lobar Degeneration |
Human |
TREM2 |
RF |
|
Homozygosity |
2018 |
29557178 |
| 2617 |
Frontotemporal Lobar Degeneration |
Human |
TREM2 |
RF |
|
T vs. C |
2018 |
29322490 |
| 2816 |
Dementia with Lewy bodies |
Human |
TREM2 |
RF |
|
|
2017 |
28003435 |
| 2552 |
Frontotemporal Lobar Degeneration |
Human |
TREM2 |
RF |
|
carrier T vs. C |
2018 |
29322490 |
| 3359 |
Alzheimer's Disease |
Human |
TREM2 |
RF |
|
|
2018 |
30222607 |
| 3012 |
Frontotemporal Lobar Degeneration |
Human |
TREM2 |
RF |
|
|
2013 |
23800361 |
| 3364 |
Frontotemporal Lobar Degeneration |
Human |
TREM2 |
RF |
|
|
2018 |
29557178 |
| 2932 |
Alzheimer's Disease |
Human |
TREM2 |
RF |
|
|
2014 |
24041969 |
| 2679 |
Frontotemporal Lobar Degeneration |
Human |
TREM2 |
RF |
|
carrier T vs. G |
2018 |
29322490 |
| 2534 |
Alzheimer's Disease |
Human |
TREM2 |
RF |
|
|
2014 |
25160042 |
| 3361 |
Frontotemporal Dementia |
Human |
TREM2 |
RF |
|
|
2018 |
29557178 |
| 3366 |
Frontotemporal Lobar Degeneration |
Human |
TREM2 |
RF |
|
|
2018 |
29557178 |
| 2681 |
Frontotemporal Lobar Degeneration |
Human |
TREM2 |
RF |
|
GT+TT vs. GG |
2018 |
29322490 |
| 2958 |
Multiple System Atrophy |
Human |
TREM2 p.R47H |
RF |
|
patients with pathologically confirmed MSA |
2018 |
30109269 |
| 1813 |
Multiple System Atrophy |
Human |
TREM2 p.R47H |
RF |
|
patients with clinically diagnosed MSA |
2018 |
30109269 |
| 2893 |
Multiple System Atrophy |
Human |
TREM2 p.R47H |
RF |
|
patients with clinically diagnosed MSA |
2018 |
30109269 |
| 1817 |
Multiple System Atrophy |
Human |
TREM2 p.R47H |
RF |
|
patients with pathologically confirmed MSA |
2018 |
30109269 |
| 811 |
Alzheimer's Disease |
Human |
TREML2 |
PF |
|
|
2014 |
24439484 |
| 3884 |
Tuberous sclerosis complex |
Human |
TSC2 |
RF |
Diagnosis |
|
2021 |
33225634 |
| 2804 |
Alzheimer's Disease |
Human |
TTC38 |
RF |
|
APOE-?2 |
2021 |
33576571 |
| 2359 |
Alzheimer's Disease |
Human |
TTLL13 |
RF |
|
APOE-?2 |
2021 |
33576571 |
| 2328 |
Alzheimer's Disease |
Human |
TTLL13 |
RF |
|
APOE-?2 |
2021 |
33576571 |
| 2987 |
Alzheimer's Disease |
Human |
TXNRD3NB |
RF |
|
APOE-?2 |
2021 |
33576571 |
| 3368 |
Alzheimer's Disease |
Human |
TYROBP |
RF |
|
|
2016 |
27658901 |
| 2031 |
Frontotemporal Lobar Degeneration |
Human |
UBAP1 |
RF |
|
Haplotype:TGC |
2009 |
19217189 |
| 2069 |
Frontotemporal Lobar Degeneration |
Human |
UBAP1 |
RF |
|
Haplotype:TGC |
2009 |
19217189 |
| 2068 |
Frontotemporal Lobar Degeneration |
Human |
UBAP1 |
RF |
|
Haplotype:GCT |
2009 |
19217189 |
| 2232 |
Alzheimer's Disease |
Human |
UBASH3B |
RF |
|
APOE-?2 |
2021 |
33576571 |
| 2173 |
Parkinson disease |
Human |
UCHL1 |
RF |
|
|
2012 |
22839974 |
| 738 |
Alzheimer's Disease |
Human |
UGT3A1 |
PF |
|
APOE-?3 |
2021 |
33576571 |
| 663 |
Alzheimer's Disease |
Human |
UGT3A1 |
PF |
|
APOE-?2 |
2021 |
33576571 |
| 2099 |
Frontotemporal Lobar Degeneration |
Human |
UNC13A |
RF |
|
Discovery stage |
2019 |
30739198 |
| 2171 |
Frontotemporal Lobar Degeneration |
Human |
UNC13A |
RF |
|
Replication stage |
2019 |
30739198 |
| 1904 |
Amyotrophic Lateral Sclerosis |
Human |
UNC13A |
RF |
|
especially in Caucasian and European subjects |
2019 |
31201598 |
| 3370 |
Amyotrophic Lateral Sclerosis |
zebrafish |
VAPB |
RF |
|
|
2013 |
23446633 |
| 3369 |
Amyotrophic Lateral Sclerosis |
Mice |
VAPB |
RF |
|
|
2013 |
23446633 |
| 3762 |
Alzheimer's Disease |
Human |
vascular apoE |
RF |
|
|
2021 |
33321072 |
| 2112 |
Parkinson disease |
Human |
VEGF |
RF |
|
|
2016 |
27481110 |
| 2020 |
Frontotemporal Lobar Degeneration |
Human |
VEGF |
RF |
|
A allele |
2008 |
18729809 |
| 2049 |
Frontotemporal Lobar Degeneration |
Human |
VEGF |
RF |
|
A allele |
2008 |
18729809 |
| 3069 |
Progressive Supranuclear Palsy |
Human |
VEGF haplotypes(AGG) |
RF |
|
|
2010 |
20413880 |
| 3852 |
Parkinson disease |
Human |
vitamin D Receptor(VDR) |
RF |
|
|
2021 |
34365149 |
| 3854 |
Parkinson disease |
Human |
vitamin D Receptor(VDR) |
RF |
|
|
2021 |
34365149 |
| 3853 |
Parkinson disease |
Human |
vitamin D Receptor(VDR) |
RF |
|
|
2021 |
34365149 |
| 3371 |
Parkinson disease |
Human |
VMAT2 |
RF |
|
|
2016 |
27137201 |
| 3020 |
Alzheimer's Disease |
Human |
VSTM5 |
RF |
|
APOE-?2 |
2021 |
33576571 |
| 3870 |
Parkinson disease |
Human |
WBSCR17 |
RF |
Diagnosis |
|
2021 |
33760272 |
| 2450 |
Amyotrophic Lateral Sclerosis |
Human |
WDR49 |
RF |
|
|
2013 |
27455347 |
| 797 |
Alzheimer's Disease |
Human |
WDR60 |
PF |
|
APOE-?3 |
2021 |
33576571 |
| 622 |
Alzheimer's Disease |
Human |
YDJC |
PF |
|
APOE-?2 |
2021 |
33576571 |
| 2182 |
Alzheimer's Disease |
Human |
ZAR1 |
RF |
|
APOE-?3 |
2021 |
33576571 |
| 2638 |
Alzheimer's Disease |
Human |
ZAR1 |
RF |
|
APOE-?2 |
2021 |
33576571 |
| 584 |
Alzheimer's Disease |
Human |
ZCCHC9 |
PF |
|
APOE-?2 |
2021 |
33576571 |
| 740 |
Parkinson disease |
Human |
ZFP64/TSHZ2 |
PF |
Diagnosis |
|
2021 |
33510632 |
| 3779 |
Amyotrophic Lateral Sclerosis |
Human |
ZNF512B |
RF |
Prognosis |
|
2021 |
33387304 |
| 2616 |
Alzheimer's Disease |
Human |
ZNF596 |
RF |
|
APOE-?2 |
2021 |
33576571 |
| 2599 |
Alzheimer's Disease |
Human |
ZNF778 |
RF |
|
APOE-?2 |
2021 |
33576571 |
| 2385 |
Alzheimer's Disease |
Human |
ZNF804B |
RF |
|
APOE-?3 |
2021 |
33576571 |
| 2493 |
Alzheimer's Disease |
Human |
ZNF90 |
RF |
|
APOE-?2 |
2021 |
33576571 |
| 2451 |
Amyotrophic Lateral Sclerosis |
Human |
ZSCAN5B |
RF |
|
|
2013 |
27455347 |
| 2775 |
Tourette Syndrome |
Human |
ADHD family history positive |
RF |
|
|
2010 |
20654033 |
| 3442 |
Tourette Syndrome |
Human |
family history |
RF |
|
|
2012 |
22738448 |
| 2300 |
Amyotrophic Lateral Sclerosis |
Human |
family history of ALS |
RF |
Diagnosis |
|
2021 |
33563800 |
| 3443 |
Alzheimer's Disease |
Human |
family history of cardiovascular diseases |
RF |
|
|
2014 |
24596166 |
| 3444 |
Dementia with Lewy bodies |
Human |
Family history of dementia |
RF |
|
|
2006 |
16801670 |
| 2705 |
Alzheimer's Disease |
Human |
Family history of dementia (FH) |
RF |
|
|
2016 |
26531229 |
| 3445 |
Alzheimer's Disease |
Human |
family history of dementia (within third-degree relatives) |
RF |
|
people with mild memory impairment/no dementia (MMI/ND) |
2011 |
21205364 |
| 2817 |
Parkinson disease |
Human |
family history of PD |
RF |
|
|
2020 |
32943485 |
| 2461 |
Tourette Syndrome |
Human |
first-degree relatives |
RF |
|
|
2015 |
26083307 |
| 1631 |
Frontotemporal Dementia |
Human |
first-degree relatives |
RF |
|
First-degree relatives(parents) |
1998 |
9633692 |
| 2743 |
Alzheimer's Disease |
Human |
Having a first-degree relative or a parent with dementia |
RF |
|
|
2016 |
26531229 |